-
3
-
-
0342444745
-
-
Academic Press, New York
-
Wooley, P.V. (1989) Cancer Management in Man: Biological Response Modifiers, Chemotherapy, Antibiotics, Hyperthermia, Supporting Measures, Academic Press, New York.
-
(1989)
Cancer Management in Man: Biological Response Modifiers, Chemotherapy, Antibiotics, Hyperthermia, Supporting Measures
-
-
Wooley, P.V.1
-
4
-
-
0001199533
-
Chemical aspects of selective toxicity
-
Albert, A. (1958) Chemical aspects of selective toxicity. Nature 182, 421-423
-
(1958)
Nature
, vol.182
, pp. 421-423
-
-
Albert, A.1
-
5
-
-
33947465814
-
Drug latentiation
-
Harper, N.J. (1959) Drug latentiation. J. Med. Pharm. Chem. 1, 467-500.
-
(1959)
J. Med. Pharm. Chem.
, vol.1
, pp. 467-500
-
-
Harper, N.J.1
-
6
-
-
0342879280
-
Prodrugs in cancer chemotherapy
-
H. Bundgaard (Ed.), Elsevier, Amsterdam
-
Connors, T.A. (1985) Prodrugs in cancer chemotherapy. In: H. Bundgaard (Ed.), Design of Prodrugs, Elsevier, Amsterdam, pp. 291-316.
-
(1985)
Design of Prodrugs
, pp. 291-316
-
-
Connors, T.A.1
-
8
-
-
21844523601
-
Prodrugs of analogs of nucleic acid components
-
Alexander, P. and Holy, A. (1994) Prodrugs of analogs of nucleic acid components. Coll. Czech. Chem. Commun. 59, 2127-2165.
-
(1994)
Coll. Czech. Chem. Commun.
, vol.59
, pp. 2127-2165
-
-
Alexander, P.1
Holy, A.2
-
10
-
-
0027984188
-
Future of prodrugs in antiviral therapy
-
Hasegawa, T. and Kawaguchi, T. (1994) Future of prodrugs in antiviral therapy. Clin. Pharmacokinet. 27, 331-336.
-
(1994)
Clin. Pharmacokinet.
, vol.27
, pp. 331-336
-
-
Hasegawa, T.1
Kawaguchi, T.2
-
11
-
-
0027268101
-
Acyclovir prodrugs: The road to valaciclovir
-
Beauchamp, L.M. and Krenitsky, T.A. (1993) Acyclovir prodrugs: the road to valaciclovir. Drugs Future 18, 619-628.
-
(1993)
Drugs Future
, vol.18
, pp. 619-628
-
-
Beauchamp, L.M.1
Krenitsky, T.A.2
-
12
-
-
0027131363
-
Penciclovir: A review of its spectrum of activity, selectivity, and cross-resistance pattern
-
Boyd, M.R., Safrin, S. and Kern, E.R. (1993) Penciclovir: a review of its spectrum of activity, selectivity, and cross-resistance pattern. Antiviral Chem. Chemother. 4, 3-11.
-
(1993)
Antiviral Chem. Chemother.
, vol.4
, pp. 3-11
-
-
Boyd, M.R.1
Safrin, S.2
Kern, E.R.3
-
13
-
-
0024246527
-
A cytotoxic agent can be generated selectively at cancer sites
-
Bagshawe, K.D., Springer, C.J., Searle, F., Antoniw, P., Melton, R.G. and Herwood, R.F. (1988) A cytotoxic agent can be generated selectively at cancer sites. Br. J. Cancer 58, 700-703.
-
(1988)
Br. J. Cancer
, vol.58
, pp. 700-703
-
-
Bagshawe, K.D.1
Springer, C.J.2
Searle, F.3
Antoniw, P.4
Melton, R.G.5
Herwood, R.F.6
-
14
-
-
0008390806
-
Antibodies as carriers of cytotoxicity
-
Karger, Basel
-
Sedlacek, H.-H., Seemann, G., Hoffman, D., Czech, J., Lorenz, P., Kolar, C. and Bosslet, K. (1992) Antibodies as Carriers of Cytotoxicity (Contributions to Oncology Vol. 43), Karger, Basel, pp. 114-208.
-
(1992)
Contributions to Oncology
, vol.43
, pp. 114-208
-
-
Sedlacek, H.-H.1
Seemann, G.2
Hoffman, D.3
Czech, J.4
Lorenz, P.5
Kolar, C.6
Bosslet, K.7
-
15
-
-
0345678344
-
Design of antitumor prodrugs: Substrates for antibody targeted enzymes
-
Jungheim, L.N. and Shepard, T.A. (1994) Design of antitumor prodrugs: substrates for antibody targeted enzymes. Chem. Rev. 94, 1553-1566.
-
(1994)
Chem. Rev.
, vol.94
, pp. 1553-1566
-
-
Jungheim, L.N.1
Shepard, T.A.2
-
16
-
-
0027942024
-
Antibody-directed enzyme prodrug therapy
-
Bagshawe, K.D. (1994) Antibody-directed enzyme prodrug therapy. Clin. Parmacokinet. 27, 368-376.
-
(1994)
Clin. Parmacokinet.
, vol.27
, pp. 368-376
-
-
Bagshawe, K.D.1
-
17
-
-
0028219716
-
Antibody-directed enzyme prodrug therapy (Adept)
-
Bagshawe, K.D. (1994) Antibody-directed enzyme prodrug therapy (Adept). J. Control. Release 28, 187-193.
-
(1994)
J. Control. Release
, vol.28
, pp. 187-193
-
-
Bagshawe, K.D.1
-
18
-
-
0028264106
-
Virus-directed enzyme/prodrug therapy (VDEPT) selectively engineering drug sensitivity into tumors
-
Huber, B.E., Richards, C.A. and Austin, E.A. (1994) Virus-directed enzyme/prodrug therapy (VDEPT) selectively engineering drug sensitivity into tumors. Ann. N.Y. Acad. Sci. 7, 104-114.
-
(1994)
Ann. N.Y. Acad. Sci.
, vol.7
, pp. 104-114
-
-
Huber, B.E.1
Richards, C.A.2
Austin, E.A.3
-
19
-
-
0028091914
-
Selective activation of anticancer prodrugs by monoclonal antibody-enzyme conjugates
-
Wallace, P.M. and Senter, P.D. (1994) Selective activation of anticancer prodrugs by monoclonal antibody-enzyme conjugates. Methods Find. Exp. Clin. Pharmacol. 16, 505-512.
-
(1994)
Methods Find. Exp. Clin. Pharmacol.
, vol.16
, pp. 505-512
-
-
Wallace, P.M.1
Senter, P.D.2
-
20
-
-
0028455028
-
Tumor targeting: Activation of prodrugs by enzyme-monoclonal antibody conjugates
-
Huennekens, F.M. (1994) Tumor targeting: activation of prodrugs by enzyme-monoclonal antibody conjugates. Trends Biotechnol. 2, 234-239.
-
(1994)
Trends Biotechnol.
, vol.2
, pp. 234-239
-
-
Huennekens, F.M.1
-
21
-
-
0027355456
-
Antibody-directed enzyme prodrug therapy (ADEPT)
-
Bagshawe, K.D. (1993) Antibody-directed enzyme prodrug therapy (ADEPT). Adv. Pharmacol. 24, 99-121.
-
(1993)
Adv. Pharmacol.
, vol.24
, pp. 99-121
-
-
Bagshawe, K.D.1
-
22
-
-
0027182862
-
The bioactivation of CB 1954 and its use as a prodrug in antibody-directed enzyme prodrug therapy (ADEPT)
-
Knox, R.J., Friedlos, F. and Boland, M.P. (1993) The bioactivation of CB 1954 and its use as a prodrug in antibody-directed enzyme prodrug therapy (ADEPT). Cancer Metastasis Rev. 12, 195-212.
-
(1993)
Cancer Metastasis Rev.
, vol.12
, pp. 195-212
-
-
Knox, R.J.1
Friedlos, F.2
Boland, M.P.3
-
23
-
-
0342444737
-
Molecular and functional characterization of a fusion protein suited for tumour specific prodrug activation
-
Epenetos, A.A. (Ed.), Chapman and Hall, London
-
Bosslet, K., Czech, J., Lorenz, P., Sedlacek, H.H., Schuermann, M. and Seemann, G. (1993) Molecular and functional characterization of a fusion protein suited for tumour specific prodrug activation. In: Epenetos, A.A. (Ed.), Monoclonal Antibodies 2: Applications in Clinical Oncology, Chapman and Hall, London, pp. 205-217.
-
(1993)
Monoclonal Antibodies 2: Applications in Clinical Oncology
, pp. 205-217
-
-
Bosslet, K.1
Czech, J.2
Lorenz, P.3
Sedlacek, H.H.4
Schuermann, M.5
Seemann, G.6
-
24
-
-
0342444735
-
Monoclonal antibody enzyme conjugates for prodrug activation: Therapeutic effects and mechanistic considerations
-
Epenetos, A.A. (Ed.), Chapman and Hall, London
-
Senter, P.D. and Wallace, P.M. (1993) Monoclonal antibody enzyme conjugates for prodrug activation: therapeutic effects and mechanistic considerations. In: Epenetos, A.A. (Ed.), Monoclonal Antibodies 2: Applications in Clinical Oncology, Chapman and Hall, London, pp. 453-461.
-
(1993)
Monoclonal Antibodies 2: Applications in Clinical Oncology
, pp. 453-461
-
-
Senter, P.D.1
Wallace, P.M.2
-
25
-
-
0027357432
-
Generation of cytotoxic agents by targeted enzymes
-
Senter, P.D., Wallace, P.M., Svensson, H.P., Vrudhula, V.M., Kerr, D.E., Hellstrom, I. and Hellstrom, K.E. (1993) Generation of cytotoxic agents by targeted enzymes. Bioconj. Chem. 4, 3-9.
-
(1993)
Bioconj. Chem.
, vol.4
, pp. 3-9
-
-
Senter, P.D.1
Wallace, P.M.2
Svensson, H.P.3
Vrudhula, V.M.4
Kerr, D.E.5
Hellstrom, I.6
Hellstrom, K.E.7
-
26
-
-
0343314235
-
Drug targeting with monoclonal antibodies
-
Blakey, D.C. (1992) Drug targeting with monoclonal antibodies. Rev. Oncol. 5, 91-97.
-
(1992)
Rev. Oncol.
, vol.5
, pp. 91-97
-
-
Blakey, D.C.1
-
27
-
-
0026328982
-
Activation of prodrugs by antibody-enzyme conjugates
-
Senter, P.D., Wallace, P.M., Svensson, H.P., Kerr, D.E., Hellstrom, I. and Hellstrom, K.E. (1991) Activation of prodrugs by antibody-enzyme conjugates. Adv. Exp. Med. Biol. 303, 97-105.
-
(1991)
Adv. Exp. Med. Biol.
, vol.303
, pp. 97-105
-
-
Senter, P.D.1
Wallace, P.M.2
Svensson, H.P.3
Kerr, D.E.4
Hellstrom, I.5
Hellstrom, K.E.6
-
28
-
-
0029145803
-
Antibody-directed enzyme prodrug therapy (ADEPT) with mustard prodrugs
-
Springer, C.J. and Niculescu-Duvaz, I. (1995) Antibody-directed enzyme prodrug therapy (ADEPT) with mustard prodrugs. Anticancer Drug Des. 10, 361-372.
-
(1995)
Anticancer Drug Des.
, vol.10
, pp. 361-372
-
-
Springer, C.J.1
Niculescu-Duvaz, I.2
-
29
-
-
0342444732
-
Antibody-directed enzyme prodrug therapy (ADEPT)
-
Baldwin, R.W., Byers, V.S. and Mann, R.D. (Eds), Parthenon, NJ
-
Bagshawe, K.D., Rogers, G.T., Sharma, S.K., Antoniw, P., Sherwood, R., Springer, C., Searle, F., Burke, P., Melton, R., Boden, J. and Green, A. (1990) Antibody-directed enzyme prodrug therapy (ADEPT). In: Baldwin, R.W., Byers, V.S. and Mann, R.D. (Eds), Monoclonal Antibodies and Immunoconjugates, Parthenon, NJ, pp. 95-102.
-
(1990)
Monoclonal Antibodies and Immunoconjugates
, pp. 95-102
-
-
Bagshawe, K.D.1
Rogers, G.T.2
Sharma, S.K.3
Antoniw, P.4
Sherwood, R.5
Springer, C.6
Searle, F.7
Burke, P.8
Melton, R.9
Boden, J.10
Green, A.11
-
30
-
-
0025174052
-
Activation of prodrugs by antibody-enzyme conjugates: A new approach to cancer therapy
-
Senter, P.D. (1990) Activation of prodrugs by antibody-enzyme conjugates: a new approach to cancer therapy. FASEB J. 4, 188-193.
-
(1990)
FASEB J.
, vol.4
, pp. 188-193
-
-
Senter, P.D.1
-
31
-
-
0025071928
-
Antitumor effects of antibody enzyme conjugates in combination with prodrugs
-
Senter, P.D. (1990) Antitumor effects of antibody enzyme conjugates in combination with prodrugs. Front. Radiat. Ther. Oncol. 24, 132-141.
-
(1990)
Front. Radiat. Ther. Oncol.
, vol.24
, pp. 132-141
-
-
Senter, P.D.1
-
32
-
-
0023619243
-
Antibody directed enzyme revive anti-cancer prodrugs concept
-
Bagshawe, K.D. (1987) Antibody directed enzyme revive anti-cancer prodrugs concept. Br. J. Cancer 56, 531-532.
-
(1987)
Br. J. Cancer
, vol.56
, pp. 531-532
-
-
Bagshawe, K.D.1
-
33
-
-
0027942213
-
Regression of established breast carcinoma xenografts with antibody-directed enzyme prodrug therapy against c-erbB2 p185
-
Eccles, S.A., Court, W.J., Box, G.A., Dean, C.J., Melton, R.G. and Springer, C.J. (1994) Regression of established breast carcinoma xenografts with antibody-directed enzyme prodrug therapy against c-erbB2 p185. Cancer Res. 54, 5171-5177.
-
(1994)
Cancer Res.
, vol.54
, pp. 5171-5177
-
-
Eccles, S.A.1
Court, W.J.2
Box, G.A.3
Dean, C.J.4
Melton, R.G.5
Springer, C.J.6
-
34
-
-
0028122014
-
Novel prodrugs of alkylating agents derived from 2-fluoro-and 3-fluorobenzoic acids for antibody-directed enzyme prodrug therapy
-
Springer, C.J., Niculescu-Duvaz, I. and Pedley, B. (1994) Novel prodrugs of alkylating agents derived from 2-fluoro-and 3-fluorobenzoic acids for antibody-directed enzyme prodrug therapy. J. Med. Chem. 37, 2361-2370.
-
(1994)
J. Med. Chem.
, vol.37
, pp. 2361-2370
-
-
Springer, C.J.1
Niculescu-Duvaz, I.2
Pedley, B.3
-
35
-
-
0028014458
-
Galactosylated antibodies and antibody-enzyme conjugates in antibody-directed enzyme prodrug therapy
-
Sharma, S.K., Bagshawe, K.D., Burke, P.J., Boden, J.A., Rogers, G.T., Springer, C.J., Melton, R.G. and Sherwood, R.F. (1994) Galactosylated antibodies and antibody-enzyme conjugates in antibody-directed enzyme prodrug therapy. Cancer 73 (Suppl. 3), 1114-1120.
-
(1994)
Cancer
, vol.73
, Issue.SUPPL. 3
, pp. 1114-1120
-
-
Sharma, S.K.1
Bagshawe, K.D.2
Burke, P.J.3
Boden, J.A.4
Rogers, G.T.5
Springer, C.J.6
Melton, R.G.7
Sherwood, R.F.8
-
36
-
-
0028694296
-
Antibody-directed enzyme prodrug therapy (ADEPT)
-
Sharma, S.K., Boden, J.A., Springer, C.J., Burke, P.J. and Bagshawe, K.D. (1994) Antibody-directed enzyme prodrug therapy (ADEPT). Cell Biophys. 24/25, 219-228.
-
(1994)
Cell Biophys.
, vol.24-25
, pp. 219-228
-
-
Sharma, S.K.1
Boden, J.A.2
Springer, C.J.3
Burke, P.J.4
Bagshawe, K.D.5
-
37
-
-
0027538972
-
Identification of prodrug, active drug, and metabolites in an ADEPT clinical study
-
Springer, C.J., Poon, G.K., Sharma, S.K. and Bagshawe, K.D. (1993) Identification of prodrug, active drug, and metabolites in an ADEPT clinical study. Cell Biophys. 2, 9-26.
-
(1993)
Cell Biophys.
, vol.2
, pp. 9-26
-
-
Springer, C.J.1
Poon, G.K.2
Sharma, S.K.3
Bagshawe, K.D.4
-
38
-
-
0027538834
-
Antitumor effects of an antibody-carboxypeptidase G2 conjugate in combination with a benzoic acid mustard prodrug
-
Blakey, D.C., Valcaccia, B.E., East, S., Wright, A.F., Boyle, F.T., Springer, C.J., Burke, P.J., Melton, R.G. and Bagshawe, K.D. (1993) Antitumor effects of an antibody-carboxypeptidase G2 conjugate in combination with a benzoic acid mustard prodrug. Cell Biophys. 22, 1-8.
-
(1993)
Cell Biophys.
, vol.22
, pp. 1-8
-
-
Blakey, D.C.1
Valcaccia, B.E.2
East, S.3
Wright, A.F.4
Boyle, F.T.5
Springer, C.J.6
Burke, P.J.7
Melton, R.G.8
Bagshawe, K.D.9
-
40
-
-
0026335039
-
Comparison of half-lives and cytotoxicity of N-chloroethyl-4-amino and N-mesyloxyethyl-benzoyl compounds, products of prodrugs in antibody-directed enzyme prodrug therapy (ADEPT)
-
Springer, C.J., Antoniw, P., Bagshawe, K.D. and Wilman, D.E.V. (1991) Comparison of half-lives and cytotoxicity of N-chloroethyl-4-amino and N-mesyloxyethyl-benzoyl compounds, products of prodrugs in antibody-directed enzyme prodrug therapy (ADEPT). Anti-Cancer Drug Des. 6, 467-479.
-
(1991)
Anti-cancer Drug Des.
, vol.6
, pp. 467-479
-
-
Springer, C.J.1
Antoniw, P.2
Bagshawe, K.D.3
Wilman, D.E.V.4
-
41
-
-
0025720744
-
Antibody directed enzyme prodrug therapy (ADEPT): A three phase system
-
Sharma, S.K., Bagshawe, K.D., Springer, C.J., Burke, P.J., Rogers, G.T., Boden, J.A., Antoniw, P., Melton, R.G. and Sherwood, R.F. (1991) Antibody directed enzyme prodrug therapy (ADEPT): a three phase system. Dis. Markers 9, 225-231.
-
(1991)
Dis. Markers
, vol.9
, pp. 225-231
-
-
Sharma, S.K.1
Bagshawe, K.D.2
Springer, C.J.3
Burke, P.J.4
Rogers, G.T.5
Boden, J.A.6
Antoniw, P.7
Melton, R.G.8
Sherwood, R.F.9
-
42
-
-
0025720558
-
Antibody directed enzyme prodrug therapy (ADEPT): Clinical report
-
Bagshawe, K.D., Sharma, S.K., Springer, C.J., Antoniw, P., Boden, J.A., Rogers, G.T., Burke, P.J., Melton, R.G. and Sherwood, R.F. (1991) Antibody directed enzyme prodrug therapy (ADEPT): clinical report. Dis. Markers 9, 233-238.
-
(1991)
Dis. Markers
, vol.9
, pp. 233-238
-
-
Bagshawe, K.D.1
Sharma, S.K.2
Springer, C.J.3
Antoniw, P.4
Boden, J.A.5
Rogers, G.T.6
Burke, P.J.7
Melton, R.G.8
Sherwood, R.F.9
-
43
-
-
0025955579
-
Ablation of human cariocarcinoma xenografts in nude mice by antibody-directed enzyme prodrug therapy (ADEPT) with three novel compounds
-
Springer, C.J., Bagshawe, K.D., Sharma, S.K., Searle, F., Boden, J.A., Antoniw, P., Burke, P.J., Rogers, G.T., Sherwood, R.F. and Melton, R.G. (1991) Ablation of human cariocarcinoma xenografts in nude mice by antibody-directed enzyme prodrug therapy (ADEPT) with three novel compounds. Eur. J. Cancer 27, 1361-1366.
-
(1991)
Eur. J. Cancer
, vol.27
, pp. 1361-1366
-
-
Springer, C.J.1
Bagshawe, K.D.2
Sharma, S.K.3
Searle, F.4
Boden, J.A.5
Antoniw, P.6
Burke, P.J.7
Rogers, G.T.8
Sherwood, R.F.9
Melton, R.G.10
-
44
-
-
0007351186
-
Antibody-enzyme conjugates can generate cytotoxic drugs from inactive precursors at tumor sites
-
Bagshawe, K.D., Sharma, S.K., Springer, C.J., Antoniw, P., Rogers, G.T., Burke, P.J., Melton, R. and Sherwood, R. (1991) Antibody-enzyme conjugates can generate cytotoxic drugs from inactive precursors at tumor sites. Antibody Immunoconj. Radiopharm. 4, 915-922.
-
(1991)
Antibody Immunoconj. Radiopharm.
, vol.4
, pp. 915-922
-
-
Bagshawe, K.D.1
Sharma, S.K.2
Springer, C.J.3
Antoniw, P.4
Rogers, G.T.5
Burke, P.J.6
Melton, R.7
Sherwood, R.8
-
45
-
-
0025189891
-
Novel prodrugs which are activated to cytotoxic alkylating agents by carboxypeptidase G2
-
Springer, C.J., Antoniw, P., Bagshawe, K.D., Searle, F., Bisset, G.M.F. and Jarman, M. (1990) Novel prodrugs which are activated to cytotoxic alkylating agents by carboxypeptidase G2. J. Med. Chem. 33, 677-681.
-
(1990)
J. Med. Chem.
, vol.33
, pp. 677-681
-
-
Springer, C.J.1
Antoniw, P.2
Bagshawe, K.D.3
Searle, F.4
Bisset, G.M.F.5
Jarman, M.6
-
46
-
-
0343749979
-
Phosphatase activated water-soluble prodrugs of taxol
-
Vyas, D.M. (1994) Phosphatase activated water-soluble prodrugs of taxol. Abstr. Pap. Am. Chem. Soc. Med. Abstr. No. 142.
-
(1994)
Abstr. Pap. Am. Chem. Soc. Med. Abstr.
, vol.142
-
-
Vyas, D.M.1
-
47
-
-
0026577584
-
Analysis of a conjugate between anti-carcinoembryonic antigen monoclonal antibody and alkaline phosphates for specific activation of the prodrug etoposide phosphate
-
Haisma, H.J., Boven, E., Van Muijen, M., De Vries, R. and Pinedo, H.M. (1992) Analysis of a conjugate between anti-carcinoembryonic antigen monoclonal antibody and alkaline phosphates for specific activation of the prodrug etoposide phosphate. Cancer Immunol. Immunother. 34, 343-348.
-
(1992)
Cancer Immunol. Immunother.
, vol.34
, pp. 343-348
-
-
Haisma, H.J.1
Boven, E.2
Van Muijen, M.3
De Vries, R.4
Pinedo, H.M.5
-
48
-
-
0026212613
-
In vitro, in vivo activities of monoclonal antibody-alkaline phosphatase conjugates in combination with phenol mustard phosphate
-
Wallace, P.M. and Senter, P.D. (1991) In vitro, in vivo activities of monoclonal antibody-alkaline phosphatase conjugates in combination with phenol mustard phosphate. Bioconj. Chem. 2, 349-352.
-
(1991)
Bioconj. Chem.
, vol.2
, pp. 349-352
-
-
Wallace, P.M.1
Senter, P.D.2
-
49
-
-
0025186181
-
Specific activation of the prodrug mitomycin phosphate by a bispecific anti-cd30/anti-alkaline phosphatase monoclonal antibody
-
Sahin, U., Hartmann, F., Senter, P., Pohl, C., Engert, A., Diehl, V. and Pfreundschuh, M. (1990) Specific activation of the prodrug mitomycin phosphate by a bispecific anti-cd30/anti-alkaline phosphatase monoclonal antibody. Cancer Res. 50, 6944-6948.
-
(1990)
Cancer Res.
, vol.50
, pp. 6944-6948
-
-
Sahin, U.1
Hartmann, F.2
Senter, P.3
Pohl, C.4
Engert, A.5
Diehl, V.6
Pfreundschuh, M.7
-
50
-
-
0024446208
-
Enhancement of the in vitro and in vivo antitumor activities of phosphorylated mitomycin C and etoposide derivatives by monoclonal antibody-alkaline phosphatase conjugates
-
Senter, P.D., Schreiber, G.J., Hirschberg, D.L., Ashe, S.A., Hellstrom, K.E. and Hellstrom, I. (1989) Enhancement of the in vitro and in vivo antitumor activities of phosphorylated mitomycin C and etoposide derivatives by monoclonal antibody-alkaline phosphatase conjugates. Cancer Res. 49, 5789-5792.
-
(1989)
Cancer Res.
, vol.49
, pp. 5789-5792
-
-
Senter, P.D.1
Schreiber, G.J.2
Hirschberg, D.L.3
Ashe, S.A.4
Hellstrom, K.E.5
Hellstrom, I.6
-
51
-
-
0024041278
-
Anti-tumor effects of antibody-alkaline phosphatase conjugates in combination with etoposide phosphate
-
Senter, P.D., Saulnier, M.G., Schreiber, G.J., Hirschberg, D.L., Brown, J.P., Hellstrom, I. and Hellstrom, K.E. (1988) Anti-tumor effects of antibody-alkaline phosphatase conjugates in combination with etoposide phosphate. Proc. Natl. Acad. Sci. USA 85, 4842-4846.
-
(1988)
Proc. Natl. Acad. Sci. USA
, vol.85
, pp. 4842-4846
-
-
Senter, P.D.1
Saulnier, M.G.2
Schreiber, G.J.3
Hirschberg, D.L.4
Brown, J.P.5
Hellstrom, I.6
Hellstrom, K.E.7
-
52
-
-
0028718114
-
Comparison of two anthracycline-based prodrugs for activation by a monoclonal antibody-β-glucuronidase conjugate in the specific treatment of cancer
-
Haisma, H.J., Van Muijen, M., Pinedo, H.M. and Boven, E. (1994) Comparison of two anthracycline-based prodrugs for activation by a monoclonal antibody-β-glucuronidase conjugate in the specific treatment of cancer. Cell Biophys. 24/25, 185-192.
-
(1994)
Cell Biophys.
, vol.24-25
, pp. 185-192
-
-
Haisma, H.J.1
Van Muijen, M.2
Pinedo, H.M.3
Boven, E.4
-
53
-
-
0028348376
-
Tumor selective prodrug activation by fusion protein-mediated catalysis
-
Bosslet, K., Czech, J. and Hoffmann, D. (1994) Tumor selective prodrug activation by fusion protein-mediated catalysis. Cancer Res. 54, 2151-2159.
-
(1994)
Cancer Res.
, vol.54
, pp. 2151-2159
-
-
Bosslet, K.1
Czech, J.2
Hoffmann, D.3
-
54
-
-
0027771449
-
A new application for liposomes in cancer therapy
-
Vingerhoeds, M.H., Haisma, H.J., Van Muijen, M., Van de Rijt, R.B.J., Crommelin, D.J.A. and Storm, G. (1993) A new application for liposomes in cancer therapy. FEBS Lett. 336, 485-490.
-
(1993)
FEBS Lett.
, vol.336
, pp. 485-490
-
-
Vingerhoeds, M.H.1
Haisma, H.J.2
Van Muijen, M.3
Van De Rijt, R.B.J.4
Crommelin, D.J.A.5
Storm, G.6
-
55
-
-
0026794283
-
Specific activation of glucuronide prodrugs by antibody-targeted enzyme conjugates for cancer therapy
-
Wang, S.-M., Chern, J.-W., Yeh, M.-Y., Ng, J.C., Tung, E. and Roffler, S.R. (1992) Specific activation of glucuronide prodrugs by antibody-targeted enzyme conjugates for cancer therapy. Cancer Res. 52, 4484-4491.
-
(1992)
Cancer Res.
, vol.52
, pp. 4484-4491
-
-
Wang, S.-M.1
Chern, J.-W.2
Yeh, M.-Y.3
Ng, J.C.4
Tung, E.5
Roffler, S.R.6
-
56
-
-
0026569992
-
Molecular and functional characterisation of a fusion protein suited for tumor specific prodrug activation
-
Bosslet, K., Czech, J., Lorenz, P., Sedlacek, H.H., Schuermann, M. and Seemann, G. (1992) Molecular and functional characterisation of a fusion protein suited for tumor specific prodrug activation. Br. J. Cancer 65, 234-238.
-
(1992)
Br. J. Cancer
, vol.65
, pp. 234-238
-
-
Bosslet, K.1
Czech, J.2
Lorenz, P.3
Sedlacek, H.H.4
Schuermann, M.5
Seemann, G.6
-
57
-
-
0026802983
-
A monoclonal antibody-β-glucuronidase conjugate as activator of the prodrug epirubicin-glucuronide for specific treatment of cancer
-
Haisma, H.J., Boven, E., Van Muijen, M., De Jong, J., Van der Vijgh, W.J.F. and Pined H.M. (1992) A monoclonal antibody-β-glucuronidase conjugate as activator of the prodrug epirubicin-glucuronide for specific treatment of cancer. Br. J. Cancer 66, 474-478.
-
(1992)
Br. J. Cancer
, vol.66
, pp. 474-478
-
-
Haisma, H.J.1
Boven, E.2
Van Muijen, M.3
De Jong, J.4
Van Der Vijgh, W.J.F.5
Pined, H.M.6
-
58
-
-
0025936081
-
Anti-neoplastic glucuronide prodrug treatment of human tumor cells targeted with a monoclonal antibody-enzyme conjugate
-
Roffler, S. (1991) Anti-neoplastic glucuronide prodrug treatment of human tumor cells targeted with a monoclonal antibody-enzyme conjugate. Biochem. Pharmacol. 42, 2062-2065.
-
(1991)
Biochem. Pharmacol.
, vol.42
, pp. 2062-2065
-
-
Roffler, S.1
-
59
-
-
0028959129
-
HER2 Fv-β-lactamase fusion protein for activation of a cephalosporin doxorubicin prodrug
-
HER2 Fv-β-lactamase fusion protein for activation of a cephalosporin doxorubicin prodrug. Cancer Res. 55, 63-70.
-
(1995)
Cancer Res.
, vol.55
, pp. 63-70
-
-
Rodriques, M.L.1
Presta, L.G.2
Knotts, C.E.3
Wirth, C.4
Mordenti, J.5
Osaka, G.6
Wong, W.L.T.7
Nuijens, A.8
Blackburn, B.9
Carter, P.10
-
60
-
-
0028425474
-
Synthesis and characterization of monoclonal antibody-β-lactamase conjugates
-
Svensson, H.P., Wallace, P.M. and Senter, P.D. (1994) Synthesis and characterization of monoclonal antibody-β-lactamase conjugates. Bioconj. Chem. 5, 262-267.
-
(1994)
Bioconj. Chem.
, vol.5
, pp. 262-267
-
-
Svensson, H.P.1
Wallace, P.M.2
Senter, P.D.3
-
61
-
-
0000814098
-
Synthesis of a cephalosporin-doxorubicin antitumor prodrug: A substrate for an antibody-targeted enzyme
-
Jungheim, L.N., Shepherd, T.A. and King, J.K. (1993) Synthesis of a cephalosporin-doxorubicin antitumor prodrug: a substrate for an antibody-targeted enzyme. Heterocycles 35, 339-347.
-
(1993)
Heterocycles
, vol.35
, pp. 339-347
-
-
Jungheim, L.N.1
Shepherd, T.A.2
King, J.K.3
-
62
-
-
0027220125
-
Site-specific prodrug activation by antibody-β-lactamase conjugates: Regression and long-term growth inhibition of human colon carcinoma xenograft models
-
Meyer, D.L., Jungheim, L.N., Law, K.L., Mikolajczyk, S.D., Shepherd, T.A., Mackensen, D.G., Briggs, S.L. and Starling, J.J. (1993) Site-specific prodrug activation by antibody-β-lactamase conjugates: regression and long-term growth inhibition of human colon carcinoma xenograft models. Cancer Res. 53, 3956-3963.
-
(1993)
Cancer Res.
, vol.53
, pp. 3956-3963
-
-
Meyer, D.L.1
Jungheim, L.N.2
Law, K.L.3
Mikolajczyk, S.D.4
Shepherd, T.A.5
Mackensen, D.G.6
Briggs, S.L.7
Starling, J.J.8
-
63
-
-
0027157591
-
Genetic construction, expression, and characterization of a single chain anti-carcinoma antibody fused to β-lactamase
-
Goshorn, S.C., Svensson, H.P., Kerr, D.E., Somerville, J.E., Senter, P.D and Fell, H.P. (1993) Genetic construction, expression, and characterization of a single chain anti-carcinoma antibody fused to β-lactamase. Cancer Res. 53, 2123-2127.
-
(1993)
Cancer Res.
, vol.53
, pp. 2123-2127
-
-
Goshorn, S.C.1
Svensson, H.P.2
Kerr, D.E.3
Somerville, J.E.4
Senter, P.D.5
Fell, H.P.6
-
64
-
-
0027235973
-
Design and sythesis of a cephalosporin-carboplatinum prodrug activatable by a β-lactamase
-
Hanessian, S. and Wang, J. (1993) Design and sythesis of a cephalosporin-carboplatinum prodrug activatable by a β-lactamase. Can. J. Chem. 71, 896-906.
-
(1993)
Can. J. Chem.
, vol.71
, pp. 896-906
-
-
Hanessian, S.1
Wang, J.2
-
65
-
-
0027655158
-
Antitumor activities of a cephalosporin prodrug in combination with monoclonal antibody-β-lactamase conjugates
-
Vrudhula, V.M., Svensson, H.P., Kennedy, K.A., Senter, P.D. and Wallace, P.M. (1993) Antitumor activities of a cephalosporin prodrug in combination with monoclonal antibody-β-lactamase conjugates. Bioconj. Chem. 4, 334-340.
-
(1993)
Bioconj. Chem.
, vol.4
, pp. 334-340
-
-
Vrudhula, V.M.1
Svensson, H.P.2
Kennedy, K.A.3
Senter, P.D.4
Wallace, P.M.5
-
66
-
-
0026826545
-
Monoclonal antibody-β-lactamase conjugates for the activities of a cephalosporin mustard prodrug
-
Svensson, H.P., Kadow, J.F., Vrudhula, V.M., Wallace, P.M. and Senter, P.D. (1992) Monoclonal antibody-β-lactamase conjugates for the activities of a cephalosporin mustard prodrug. Bioconj. Chem. 3, 176-181.
-
(1992)
Bioconj. Chem.
, vol.3
, pp. 176-181
-
-
Svensson, H.P.1
Kadow, J.F.2
Vrudhula, V.M.3
Wallace, P.M.4
Senter, P.D.5
-
67
-
-
0343749971
-
Radioimmunoconjugates in cancer therapy
-
Goldenberg, D.M., Blumenthal, R.D. and Sharkey, R.M. (1993) Radioimmunoconjugates in cancer therapy. Proc. Am. Assoc. Cancer Res. 34, 623-624.
-
(1993)
Proc. Am. Assoc. Cancer Res.
, vol.34
, pp. 623-624
-
-
Goldenberg, D.M.1
Blumenthal, R.D.2
Sharkey, R.M.3
-
68
-
-
0026562808
-
Synthesis of acylhydrazido-substituted cephems, design of cephalosporin-vinca alkaloid prodrugs: Substrates for an antibody-targeted enzyme
-
Jungheim, L.N., Shepherd, T.A. and Meyer, D.L. (1992) Synthesis of acylhydrazido-substituted cephems, design of cephalosporin-vinca alkaloid prodrugs: substrates for an antibody-targeted enzyme. J. Org. Chem. 57, 2334-2340.
-
(1992)
J. Org. Chem.
, vol.57
, pp. 2334-2340
-
-
Jungheim, L.N.1
Shepherd, T.A.2
Meyer, D.L.3
-
69
-
-
0026487592
-
Preparation and characterization of a β-lactamase-fab′ conjugate for the site specific activation of oncolytic agents
-
Meyer, D.L., Jungheim, L.N., Mikolajczyk, S.D., Shepherd, T.A., Starling. J.J. and Ahlem, C.N. (1992) Preparation and characterization of a β-lactamase-fab′ conjugate for the site specific activation of oncolytic agents. Bioconj. Chem. 3, 42-48.
-
(1992)
Bioconj. Chem.
, vol.3
, pp. 42-48
-
-
Meyer, D.L.1
Jungheim, L.N.2
Mikolajczyk, S.D.3
Shepherd, T.A.4
Starling, J.J.5
Ahlem, C.N.6
-
70
-
-
0025864963
-
A novel targeted delivery system utilizing a cephalosporin-oncolytic prodrug activated by an antibody β-lactamase conjugate for the treatment of cancer
-
Shepherd, T.A., Jungheim, L.N., Meyer, D.L. and Starling, J.J. (1991) A novel targeted delivery system utilizing a cephalosporin-oncolytic prodrug activated by an antibody β-lactamase conjugate for the treatment of cancer. Bioorg. Med. Chem. Lett. 1, 21-26.
-
(1991)
Bioorg. Med. Chem. Lett.
, vol.1
, pp. 21-26
-
-
Shepherd, T.A.1
Jungheim, L.N.2
Meyer, D.L.3
Starling, J.J.4
-
71
-
-
0026536712
-
Activation of methotrexate-α-alanine by carboxypeptidase A-monoclonal antibody conjugate
-
Haenseler, E., Esswein, A., Vitols, K.S., Montejano, Y., Mueller, B.M., Reisfeld, R.A. and Huennekens, F.M. (1992) Activation of methotrexate-α-alanine by carboxypeptidase A-monoclonal antibody conjugate. Biochemistry 31, 891-897.
-
(1992)
Biochemistry
, vol.31
, pp. 891-897
-
-
Haenseler, E.1
Esswein, A.2
Vitols, K.S.3
Montejano, Y.4
Mueller, B.M.5
Reisfeld, R.A.6
Huennekens, F.M.7
-
72
-
-
0011489533
-
Activation of methotrexate prodrugs by enzyme/monoclonal antibody conjugates
-
Vitols, K.S., Haenseler, E., Montejano, Y., Baer, T. and Huennekens, F.M. (1992) Activation of methotrexate prodrugs by enzyme/monoclonal antibody conjugates. Pteridines 3, 125-126.
-
(1992)
Pteridines
, vol.3
, pp. 125-126
-
-
Vitols, K.S.1
Haenseler, E.2
Montejano, Y.3
Baer, T.4
Huennekens, F.M.5
-
73
-
-
0028426915
-
Gene therapy for cancer using tumour-specific prodrug activation
-
Harris, J.D., Gutierrez, A.A., Hurst, H.C., Sikora, K. and Lemoine, N.R. (1994) Gene therapy for cancer using tumour-specific prodrug activation. Gene Ther. 1, 170-175.
-
(1994)
Gene Ther.
, vol.1
, pp. 170-175
-
-
Harris, J.D.1
Gutierrez, A.A.2
Hurst, H.C.3
Sikora, K.4
Lemoine, N.R.5
-
74
-
-
0026250463
-
Generation of 5-fluorocytosine by monoclonal antibody cytosine deaminase conjugates
-
Senter, P.D., Su, P.C.D., Katsuragi, T., Sakai, T., Cosand, W.L., Hellstrom, I. and Hellstrom, K.E. (1991) Generation of 5-fluorocytosine by monoclonal antibody cytosine deaminase conjugates. Bioconj. Chem. 2, 447-451.
-
(1991)
Bioconj. Chem.
, vol.2
, pp. 447-451
-
-
Senter, P.D.1
Su, P.C.D.2
Katsuragi, T.3
Sakai, T.4
Cosand, W.L.5
Hellstrom, I.6
Hellstrom, K.E.7
-
75
-
-
0028043912
-
Prodrugs of anthracyclines for chemotherapy via enzyme-monoclonal antibody conjugates
-
Gesson, J.-P., Jacquesy, J.-C., Mondon, M., Petit, P., Renoux, B., Andrianomenjanahary, S., Van, H.D.-T., Koch, M., Michel, S., Tillequin, F., Florent, J.-C., Monneret, C., Bosslet, K., Czech, J. and Hoffmann, D. (1994) Prodrugs of anthracyclines for chemotherapy via enzyme-monoclonal antibody conjugates. Anti-Cancer Drug Des. 9, 409-423.
-
(1994)
Anti-cancer Drug Des.
, vol.9
, pp. 409-423
-
-
Gesson, J.-P.1
Jacquesy, J.-C.2
Mondon, M.3
Petit, P.4
Renoux, B.5
Andrianomenjanahary, S.6
Van, H.D.-T.7
Koch, M.8
Michel, S.9
Tillequin, F.10
Florent, J.-C.11
Monneret, C.12
Bosslet, K.13
Czech, J.14
Hoffmann, D.15
-
76
-
-
0028090161
-
Self-immolative prodrugs: Candidates for antibody-directed enzyme prodrug therapy in conjunction with a nitroreductase enzyme
-
Mauger, A.B., Burke, P.J., Somani, H.H., Friedlos, F. and Knox, R.J. (1994) Self-immolative prodrugs: candidates for antibody-directed enzyme prodrug therapy in conjunction with a nitroreductase enzyme. J. Med. Chem. 37, 3452-3458.
-
(1994)
J. Med. Chem.
, vol.37
, pp. 3452-3458
-
-
Mauger, A.B.1
Burke, P.J.2
Somani, H.H.3
Friedlos, F.4
Knox, R.J.5
-
77
-
-
0026670255
-
N-(4′-hydroxyphenylacetyl) palytoxin: A palytoxin prodrug that can be activated by a monoclonal antibody-penicillin G amidase conjugate
-
Bignami, G.S., Senter, P.D., Grothaus. P.G., Fischer, K.J., Humphreys, T. and Wallace, P.M. (1992) N-(4′-hydroxyphenylacetyl) palytoxin: a palytoxin prodrug that can be activated by a monoclonal antibody-penicillin G amidase conjugate. Cancer Res. 52, 5759-5764.
-
(1992)
Cancer Res.
, vol.52
, pp. 5759-5764
-
-
Bignami, G.S.1
Senter, P.D.2
Grothaus, P.G.3
Fischer, K.J.4
Humphreys, T.5
Wallace, P.M.6
-
78
-
-
0025352171
-
Antibody-penicillin-V-amidase conjugates kill antigen-positive tumor cells when combined with doxorubicin phenoxyacetamide
-
Kerr, D.E., Senter, P.D., Burnett, W.V., Hirschberg, D.L., Hellstrom, I and Hellstrom, K.E. (1990) Antibody-penicillin-V-amidase conjugates kill antigen-positive tumor cells when combined with doxorubicin phenoxyacetamide. Cancer Immunol. Immunother. 31, 202-206.
-
(1990)
Cancer Immunol. Immunother.
, vol.31
, pp. 202-206
-
-
Kerr, D.E.1
Senter, P.D.2
Burnett, W.V.3
Hirschberg, D.L.4
Hellstrom, I.5
Hellstrom, K.E.6
-
79
-
-
0027537670
-
Prodrugs of doxorubicin and melphalan and their activation by a monoclonal antibody-penicillin-G amidase conjugate
-
Vrudhula, V.M., Senter, P.D., Fischer, K.J. and Wallace, P.M. (1993) Prodrugs of doxorubicin and melphalan and their activation by a monoclonal antibody-penicillin-G amidase conjugate. J. Med. Chem. 36, 919-923.
-
(1993)
J. Med. Chem.
, vol.36
, pp. 919-923
-
-
Vrudhula, V.M.1
Senter, P.D.2
Fischer, K.J.3
Wallace, P.M.4
-
80
-
-
0006153208
-
-
Borrebaeck, C.A.K. and Larrick, J.W. (Eds), Stockton Press, Houndmills
-
Borrebaeck, C.A.K., Danielsson, L., Ohlin, M., Carlsson, J. and Carlsson, R. (1990) In: Borrebaeck, C.A.K. and Larrick, J.W. (Eds), Therapeutic Monoclonal Antibodies, Stockton Press, Houndmills, pp. 1-15.
-
(1990)
Therapeutic Monoclonal Antibodies
, pp. 1-15
-
-
Borrebaeck, C.A.K.1
Danielsson, L.2
Ohlin, M.3
Carlsson, J.4
Carlsson, R.5
-
81
-
-
0024573728
-
A new strategy for the generation of catalytic antibodies
-
Shokat, K.M., Leumann, C.J., Sugasawara, R. and Schultz, P.G. (1989) A new strategy for the generation of catalytic antibodies. Nature 338, 269-274.
-
(1989)
Nature
, vol.338
, pp. 269-274
-
-
Shokat, K.M.1
Leumann, C.J.2
Sugasawara, R.3
Schultz, P.G.4
-
82
-
-
0023203173
-
Biodistribution of antibodies after intra-peritoneal and intravenous injection and effect of carbohydrate modification
-
Mattes M.J. (1987) Biodistribution of antibodies after intra-peritoneal and intravenous injection and effect of carbohydrate modification. J. Natl. Cancer Inst. 79, 855-863.
-
(1987)
J. Natl. Cancer Inst.
, vol.79
, pp. 855-863
-
-
Mattes, M.J.1
-
83
-
-
0025373638
-
Inactivation and clearance of an anti-CEA carboxypeptidase G2 conjugate in blood after localisation in a xenograft model
-
Sharma, S.K., Bagshawe, K.D. Burke, P.J., Boden, R.W. and Rogers, G.T. (1990) Inactivation and clearance of an anti-CEA carboxypeptidase G2 conjugate in blood after localisation in a xenograft model. Br. J. Cancer 61 659-62.
-
(1990)
Br. J. Cancer
, vol.61
, pp. 659-662
-
-
Sharma, S.K.1
Bagshawe, K.D.2
Burke, P.J.3
Boden, R.W.4
Rogers, G.T.5
-
84
-
-
0025894117
-
Galactose-conjugated antibodies in cancer therapy: Properties and principles of action
-
Ong, C.L., Ettenson, D., Sharkey, R.M., Marks, A., Baumal, R., Goldenberg, D.M. and Mattes, M.J. (1991) Galactose-conjugated antibodies in cancer therapy: properties and principles of action. Cancer Res. 51, 1619-1626.
-
(1991)
Cancer Res.
, vol.51
, pp. 1619-1626
-
-
Ong, C.L.1
Ettenson, D.2
Sharkey, R.M.3
Marks, A.4
Baumal, R.5
Goldenberg, D.M.6
Mattes, M.J.7
-
85
-
-
0027288316
-
SR 4233 (Tirapazamine): A new anticancer drug exploiting hypoxia in solid tumours
-
Brown, J.M. (1993) SR 4233 (Tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours. Br. J. Cancer 67, 1163-1170.
-
(1993)
Br. J. Cancer
, vol.67
, pp. 1163-1170
-
-
Brown, J.M.1
-
86
-
-
0023082510
-
Tumor hypoxia: Its impact on cancer therapy
-
Moulder, J.E. and Rockwell, S. (1987). Tumor hypoxia: its impact on cancer therapy. Cancer Metastasis Rev. 5, 313-341.
-
(1987)
Cancer Metastasis Rev.
, vol.5
, pp. 313-341
-
-
Moulder, J.E.1
Rockwell, S.2
-
88
-
-
0019849354
-
Intracapillary oxyhemoglobin saturation of malignant tumors in humans
-
Mueller-Klieser, W., Vaupel, P., Manz, R. and Schmidseder, R. (1981) Intracapillary oxyhemoglobin saturation of malignant tumors in humans. Int. J. Radiat. Oncol. Biol. Phys. 7, 1397-1404.
-
(1981)
Int. J. Radiat. Oncol. Biol. Phys.
, vol.7
, pp. 1397-1404
-
-
Mueller-Klieser, W.1
Vaupel, P.2
Manz, R.3
Schmidseder, R.4
-
89
-
-
0025807618
-
Oxygenation of human tumors: Evaluation of tissue oxygen distribution in breast cancers by computerized oxygen tension measurements
-
Vaupel, P., Schlenger, K., Knoop, C. and Hockel, M. (1991) Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized oxygen tension measurements. Cancer Res. 51 3316-3322.
-
(1991)
Cancer Res.
, vol.51
, pp. 3316-3322
-
-
Vaupel, P.1
Schlenger, K.2
Knoop, C.3
Hockel, M.4
-
90
-
-
0023555121
-
Hypoxic cell as specified drug targets for chemotherapy
-
Kennedy, K.A. (1987) Hypoxic cell as specified drug targets for chemotherapy. Anticancer Drug Des. 2, 181-194.
-
(1987)
Anticancer Drug Des.
, vol.2
, pp. 181-194
-
-
Kennedy, K.A.1
-
91
-
-
0023902264
-
Therapeutic attack of hypoxic cells of solid tumors: Presidential address
-
Sartorelli, A.C. (1988). Therapeutic attack of hypoxic cells of solid tumors: presidential address. Cancer Res. 48, 775-778.
-
(1988)
Cancer Res.
, vol.48
, pp. 775-778
-
-
Sartorelli, A.C.1
-
92
-
-
0019491278
-
Response of Chinese hamster ovary cells to anticancer drugs under aerobic and hypoxic conditions
-
Tannock, I. and Guttman, P. (1981) Response of Chinese hamster ovary cells to anticancer drugs under aerobic and hypoxic conditions. Br. J. Cancer 42, 245-248.
-
(1981)
Br. J. Cancer
, vol.42
, pp. 245-248
-
-
Tannock, I.1
Guttman, P.2
-
93
-
-
0015451983
-
Potential bioreductive alkylating agents. 1. Benzoquinone derivatives
-
Lin, A.J., Cosby, L.A., Shansky, C.W. and Sartorelli, A.C. (1972) Potential bioreductive alkylating agents. 1. Benzoquinone derivatives. J. Med. Chem. 15, 1247-1252.
-
(1972)
J. Med. Chem.
, vol.15
, pp. 1247-1252
-
-
Lin, A.J.1
Cosby, L.A.2
Shansky, C.W.3
Sartorelli, A.C.4
-
94
-
-
0001918114
-
Hypoxia-selective cytotoxins
-
Foye, W.O. (Ed.), American Chemical Society, Washington, DC
-
Denny, W.A. (1995) Hypoxia-selective cytotoxins. In: Foye, W.O. (Ed.), Cancer Chemotherapeutic Agents, American Chemical Society, Washington, DC, pp. 483-497.
-
(1995)
Cancer Chemotherapeutic Agents
, pp. 483-497
-
-
Denny, W.A.1
-
95
-
-
0023892307
-
The metabolic activation of nitroheterocyclic therapeutic agents
-
Kedderis, G.L. and Miwa, G.T. (1988) The metabolic activation of nitroheterocyclic therapeutic agents. Drug Metab. Rev. 19, 33-62.
-
(1988)
Drug Metab. Rev.
, vol.19
, pp. 33-62
-
-
Kedderis, G.L.1
Miwa, G.T.2
-
96
-
-
0024346918
-
NLP-1: A DNA intercalating hypoxic cell radiosensitizer and cytotoxin
-
Panicucci, R., Heal, R., Laderoute, K., Cowan, D.M.S., McClelland, R.A. and Rauth, A.M. (1989) NLP-1: a DNA intercalating hypoxic cell radiosensitizer and cytotoxin. Int. J. Radiat. Oncol. Biol. Phys. 16, 1039-1043.
-
(1989)
Int. J. Radiat. Oncol. Biol. Phys.
, vol.16
, pp. 1039-1043
-
-
Panicucci, R.1
Heal, R.2
Laderoute, K.3
Cowan, D.M.S.4
McClelland, R.A.5
Rauth, A.M.6
-
97
-
-
0021362088
-
Relationships between functionality and genetic toxicology of selected DNA-damaging agents
-
Brendel, M. and Ruhland, A. (1984) Relationships between functionality and genetic toxicology of selected DNA-damaging agents. Mutat. Res. 133, 51-85.
-
(1984)
Mutat. Res.
, vol.133
, pp. 51-85
-
-
Brendel, M.1
Ruhland, A.2
-
98
-
-
0025776614
-
Targeting radiosensitizers to DNA by attachment of an intercalating group: Nitroimidazole-linked phenanthridines
-
Cowan, D.M.S., Panicucci, R., McClelland, R.A. and Rauth, A.M. (1991) Targeting radiosensitizers to DNA by attachment of an intercalating group: nitroimidazole-linked phenanthridines. Radiat Res. 127, 81-89.
-
(1991)
Radiat Res.
, vol.127
, pp. 81-89
-
-
Cowan, D.M.S.1
Panicucci, R.2
McClelland, R.A.3
Rauth, A.M.4
-
99
-
-
0026536057
-
LA-1: A 2-nitroimidazole radiosensitizer targeted to DNA by intercalation
-
Denny, W.A., Roberts, P.B., Anderson, R.F., Brown, J.M. and Wilson, W.R. (1992) LA-1: a 2-nitroimidazole radiosensitizer targeted to DNA by intercalation. Int. J. Radiat. Oncol. Biol. Phys. 22, 553-556.
-
(1992)
Int. J. Radiat. Oncol. Biol. Phys.
, vol.22
, pp. 553-556
-
-
Denny, W.A.1
Roberts, P.B.2
Anderson, R.F.3
Brown, J.M.4
Wilson, W.R.5
-
100
-
-
0023228137
-
Induction of DNA crosslinks in vitro upon reduction of the nitroimidazole aziridines RSU-1069 and RSU 1131
-
O'Neill, P., McNeil, S.S. and Jenkins, T.C. (1987) Induction of DNA crosslinks in vitro upon reduction of the nitroimidazole aziridines RSU-1069 and RSU 1131. Biochem. Pharmacol. 36, 1787-1792.
-
(1987)
Biochem. Pharmacol.
, vol.36
, pp. 1787-1792
-
-
O'Neill, P.1
McNeil, S.S.2
Jenkins, T.C.3
-
101
-
-
0021260987
-
Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivo
-
Adams, G.E., Ahmed, I., Sheldon, P.W. and Stratford, I.J. (1984) Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivo. Br. J. Cancer 40, 571-577.
-
(1984)
Br. J. Cancer
, vol.40
, pp. 571-577
-
-
Adams, G.E.1
Ahmed, I.2
Sheldon, P.W.3
Stratford, I.J.4
-
102
-
-
0025117882
-
Synthesis and evaluation of novel electrophilic nitrofuran carboxamides and carboxylates as radiosensitizers and bioreductively activated cytotoxins
-
Naylor, M.A., Stephens, M.A., Cole, S., Threadgill, M.D., Stratford, I.J., O'Neill, P., Fielden, E.M. and Adams, G.E. (1990) Synthesis and evaluation of novel electrophilic nitrofuran carboxamides and carboxylates as radiosensitizers and bioreductively activated cytotoxins. J. Med. Chem. 33, 2603-2610.
-
(1990)
J. Med. Chem.
, vol.33
, pp. 2603-2610
-
-
Naylor, M.A.1
Stephens, M.A.2
Cole, S.3
Threadgill, M.D.4
Stratford, I.J.5
O'Neill, P.6
Fielden, E.M.7
Adams, G.E.8
-
103
-
-
0022486242
-
Studies of the in vivo and in vitro cytotoxicity of the drug RSU-1069
-
Hill, R.P., Guylas, S. and Whitmore, G.F. (1986) Studies of the in vivo and in vitro cytotoxicity of the drug RSU-1069. Br. J. Cancer 53, 743-751.
-
(1986)
Br. J. Cancer
, vol.53
, pp. 743-751
-
-
Hill, R.P.1
Guylas, S.2
Whitmore, G.F.3
-
104
-
-
0025744391
-
Aziridinyl nitropyrroles and nitropyrazoles as hypoxia-selective cytotoxins and radiosensitizers
-
Naylor, M.A., Stephens, M.A., Stratford, I.J., Koehane, A., O'Neill, P., Threadgill, M.D., Webb, P., Fielden, E.M. and Adams, G.E. (1991) Aziridinyl nitropyrroles and nitropyrazoles as hypoxia-selective cytotoxins and radiosensitizers. Anti-Cancer Drug Des. 6, 151-167.
-
(1991)
Anti-cancer Drug Des.
, vol.6
, pp. 151-167
-
-
Naylor, M.A.1
Stephens, M.A.2
Stratford, I.J.3
Koehane, A.4
O'Neill, P.5
Threadgill, M.D.6
Webb, P.7
Fielden, E.M.8
Adams, G.E.9
-
105
-
-
0025915256
-
Synthesis of a series of nitrothiophenes with basic or electrophilic substituents and evaluation as radiosensitizers and as bioreductively activated cytotoxins
-
Threadgill, M.D., Webb, P., O'Neill, P., Naylor, M.A., Stephens, M.A., Stratford, I.J., Cole, S., Adams, G.E. and Fieldon, E.M. (1991) Synthesis of a series of nitrothiophenes with basic or electrophilic substituents and evaluation as radiosensitizers and as bioreductively activated cytotoxins. J. Med. Chem. 34, 2112-2120.
-
(1991)
J. Med. Chem.
, vol.34
, pp. 2112-2120
-
-
Threadgill, M.D.1
Webb, P.2
O'Neill, P.3
Naylor, M.A.4
Stephens, M.A.5
Stratford, I.J.6
Cole, S.7
Adams, G.E.8
Fieldon, E.M.9
-
106
-
-
0025023154
-
Synthesis and evaluation of α-[[(2-haloethyl)amino]methyl]-2-nitro-1H-imidazole-1-ethanols as prodrugs of α-[(1-aziridinyl)methyl]-2-nitro-1H-imidazole-1-ethanol (RS-U-1069) and its analogs which are radiosensitizers and bioreductively activated cytotoxins
-
Jenkins, T.C., Naylor, M.A., O'Neill, P., Threadgill, M.D., Cole, S., Stratford, I.J., Adams, G.E., Fielden, E.M., Suto, M.J. and Stier, M.A. (1990) Synthesis and evaluation of α-[[(2-haloethyl)amino]methyl]-2-nitro-1H-imidazole-1-ethanols as prodrugs of α-[(1-aziridinyl)methyl]-2-nitro-1H-imidazole-1-ethanol (RS-U-1069) and its analogs which are radiosensitizers and bioreductively activated cytotoxins. J. Med. Chem. 33, 2603-2610.
-
(1990)
J. Med. Chem.
, vol.33
, pp. 2603-2610
-
-
Jenkins, T.C.1
Naylor, M.A.2
O'Neill, P.3
Threadgill, M.D.4
Cole, S.5
Stratford, I.J.6
Adams, G.E.7
Fielden, E.M.8
Suto, M.J.9
Stier, M.A.10
-
107
-
-
0025826381
-
Oral (po) dosing with RSU 1069 or RB 6145 maintains their potency as hypoxic cell radiosensitizers and cytotoxins but reduces systemic toxicity compared with parenteral (ip) administration in mice
-
Cole, S., Stratford, I.J., Bowler, J., Nolan, J., Wright, E.J., Lorimore, S.A. and Adams, G.E. (1991) Oral (po) dosing with RSU 1069 or RB 6145 maintains their potency as hypoxic cell radiosensitizers and cytotoxins but reduces systemic toxicity compared with parenteral (ip) administration in mice. Int. J. Radiat. Oncol. Biol. Phys. 21, 387-395.
-
(1991)
Int. J. Radiat. Oncol. Biol. Phys.
, vol.21
, pp. 387-395
-
-
Cole, S.1
Stratford, I.J.2
Bowler, J.3
Nolan, J.4
Wright, E.J.5
Lorimore, S.A.6
Adams, G.E.7
-
108
-
-
0026072447
-
Pharmacokinetic contribution to the improved therapeutic selectivity of a novel bromoethylamino prodrug (RB 6145) of the mixed function hypoxic cell sensitizer/cytotoxin α-(1-aziridinomethyl)-2-nitro-1H-imadazole-1 -ethanol (RSU 1069)
-
Binger, M. and Workman, P.J. (1991) Pharmacokinetic contribution to the improved therapeutic selectivity of a novel bromoethylamino prodrug (RB 6145) of the mixed function hypoxic cell sensitizer/cytotoxin α-(1-aziridinomethyl)-2-nitro-1H-imadazole-1 -ethanol (RSU 1069). Cancer Chemother. Pharmacol. 29, 37-47.
-
(1991)
Cancer Chemother. Pharmacol.
, vol.29
, pp. 37-47
-
-
Binger, M.1
Workman, P.J.2
-
109
-
-
0027290844
-
Assessing the bioreductive effectiveness of the nitroimidazole RSU1069 and its prodrug RB6145: With particular reference to in vivo methods of evaluation
-
Bremner, J.CM. (1993) Assessing the bioreductive effectiveness of the nitroimidazole RSU1069 and its prodrug RB6145: with particular reference to in vivo methods of evaluation. Cancer Metastasis Rev. 12, 177-193.
-
(1993)
Cancer Metastasis Rev.
, vol.12
, pp. 177-193
-
-
Bremner, J.C.M.1
-
110
-
-
0009632695
-
Tumor targeting by reductive activation of nitroimidazole carbamates
-
Allen, J. and Voges, R. (Eds), Wiley, Chichester
-
Prakash, S.R., Correa, I.D., Gan, L.-S., Chism, J.P., Arrendale, R.F., Miwa, G.T. and Thakker, D.T. (1995) Tumor targeting by reductive activation of nitroimidazole carbamates. In: Allen, J. and Voges, R. (Eds), Synthesis and Applications of Isotopically Labeled Compounds - 1994. Wiley, Chichester, pp. 573-576.
-
(1995)
Synthesis and Applications of Isotopically Labeled Compounds - 1994
, pp. 573-576
-
-
Prakash, S.R.1
Correa, I.D.2
Gan, L.-S.3
Chism, J.P.4
Arrendale, R.F.5
Miwa, G.T.6
Thakker, D.T.7
-
111
-
-
0025078217
-
Antitumor efficacy of PD115934 (NSC 366140) against solid tumors of mice
-
LoRusso, P., Wozniak, A.J., Polin, L., Capps, D., Leopold, W.R., Werbel, L.M., Biernat, L., Dan, M.A., Corbett, T.H. (1990) Antitumor efficacy of PD115934 (NSC 366140) against solid tumors of mice. Cancer Res. 50, 4900-4905.
-
(1990)
Cancer Res.
, vol.50
, pp. 4900-4905
-
-
LoRusso, P.1
Wozniak, A.J.2
Polin, L.3
Capps, D.4
Leopold, W.R.5
Werbel, L.M.6
Biernat, L.7
Dan, M.A.8
Corbett, T.H.9
-
112
-
-
0023218399
-
Pyrazoloacridines, a new class of anticancer agents with selectivity against solid tumors in vitro
-
Sebolt, J.S., Scavone, S.V., Pinter, C.D., Hamelehle, K.I., von Hoff, D.D. and Jackson, R.C. (1987) Pyrazoloacridines, a new class of anticancer agents with selectivity against solid tumors in vitro. Cancer Res. 47, 4299-4304.
-
(1987)
Cancer Res.
, vol.47
, pp. 4299-4304
-
-
Sebolt, J.S.1
Scavone, S.V.2
Pinter, C.D.3
Hamelehle, K.I.4
Von Hoff, D.D.5
Jackson, R.C.6
-
113
-
-
0021328025
-
Selective toxicity of nitracrine to hypoxic mammalian cells
-
Wilson, W.R., Denny, W.A., Twigden, S.J., Baguley, B.C. and Probert, J.C. (1984) Selective toxicity of nitracrine to hypoxic mammalian cells. Br. J. Cancer 49, 215-223.
-
(1984)
Br. J. Cancer
, vol.49
, pp. 215-223
-
-
Wilson, W.R.1
Denny, W.A.2
Twigden, S.J.3
Baguley, B.C.4
Probert, J.C.5
-
114
-
-
0024491246
-
Hypoxia-selecive antitumor agents. 1. Relationships between structure, redox properties and hypoxia-selective cytotoxicity for 4-substituted derivatives of nitracrine
-
Wilson, W.R., Anderson, R.F. and Denny, W.A. (1989) Hypoxia-selecive antitumor agents. 1. Relationships between structure, redox properties and hypoxia-selective cytotoxicity for 4-substituted derivatives of nitracrine. J. Med. Chem. 32, 23-30.
-
(1989)
J. Med. Chem.
, vol.32
, pp. 23-30
-
-
Wilson, W.R.1
Anderson, R.F.2
Denny, W.A.3
-
115
-
-
0022469354
-
Reductive metabolism and hypoxia-selective toxicity of nitracrine
-
Wilson, W.R., Denny, W.A., Stewart, G.M., Fenn, A. and Probert, J.C. (1986) Reductive metabolism and hypoxia-selective toxicity of nitracrine. Int. J. Radiat. Oncol. Biol. Phys. 12, 1235-1238.
-
(1986)
Int. J. Radiat. Oncol. Biol. Phys.
, vol.12
, pp. 1235-1238
-
-
Wilson, W.R.1
Denny, W.A.2
Stewart, G.M.3
Fenn, A.4
Probert, J.C.5
-
116
-
-
0024529829
-
Hypoxia-selective antitumor agents. 2. Electronic effects of 4-substituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives
-
Wilson, W.R., Thompson, L.H., Anderson, R.F. and Denny, W.A. (1989) Hypoxia-selective antitumor agents. 2. Electronic effects of 4-substituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives. J. Med. Chem. 32, 31-38.
-
(1989)
J. Med. Chem.
, vol.32
, pp. 31-38
-
-
Wilson, W.R.1
Thompson, L.H.2
Anderson, R.F.3
Denny, W.A.4
-
117
-
-
37049070925
-
Effect of reduction potential, on the rate of reduction of nitroacridines by xanthine oxidase and by dihydroflavin mononucleotide
-
OConnor, C.J., Denny, W.A., McLennan, D.J., Sutton, B.M. and Wilson, W.R. (1991) Effect of reduction potential, on the rate of reduction of nitroacridines by xanthine oxidase and by dihydroflavin mononucleotide. J. Chem Soc. Perkin Trans. II. 951-954.
-
(1991)
J. Chem Soc. Perkin Trans.
, vol.2
, pp. 951-954
-
-
Oconnor, C.J.1
Denny, W.A.2
McLennan, D.J.3
Sutton, B.M.4
Wilson, W.R.5
-
118
-
-
0027219332
-
Bioreducible mustards: A paradigm for hypoxia-selective prodrugs of diffusible cytotoxins (HPDCs)
-
Denny, W.A. and Wilson, W.R. (1993) Bioreducible mustards: a paradigm for hypoxia-selective prodrugs of diffusible cytotoxins (HPDCs). Cancer Metastasis Rev. 12, 135-151.
-
(1993)
Cancer Metastasis Rev.
, vol.12
, pp. 135-151
-
-
Denny, W.A.1
Wilson, W.R.2
-
119
-
-
0011942747
-
Nitroacridines and nitroquinolines as DNA-affinic hypoxia-selective cytotoxins
-
Adams, G.E., Breccia, A., Wardman, P. and Fielden, E.M. (Eds), Activation of Drugs by Redox Processes Plenum Press, New York
-
Denny, W.A., Wilson, W.R., Atwell, G.J., Boyd, M., Pullen, S.M. and Anderson, R.F. (1990) Nitroacridines and nitroquinolines as DNA-affinic hypoxia-selective cytotoxins. In: Adams, G.E., Breccia, A., Wardman, P. and Fielden, E.M. (Eds), Activation of Drugs by Redox Processes (NATO Adv. Study Ser. Vol. 198), Plenum Press, New York, pp. 149-158.
-
(1990)
NATO Adv. Study Ser.
, vol.198
, pp. 149-158
-
-
Denny, W.A.1
Wilson, W.R.2
Atwell, G.J.3
Boyd, M.4
Pullen, S.M.5
Anderson, R.F.6
-
120
-
-
0022535929
-
Considerations for the design of nitrophenyl mustards as agents with selective toxicity for hypoxic tumor cells
-
Denny, W.A. and Wilson, W.R. (1986) Considerations for the design of nitrophenyl mustards as agents with selective toxicity for hypoxic tumor cells. J. Med. Chem. 29, 879-887.
-
(1986)
J. Med. Chem.
, vol.29
, pp. 879-887
-
-
Denny, W.A.1
Wilson, W.R.2
-
121
-
-
0001759117
-
Enzyme inhibition by nitro and nitroso compounds
-
Alston, T.A., Proter, D.J.T. and Bright, H.J. (1983) Enzyme inhibition by nitro and nitroso compounds. Acc. Chem. Res. 16, 418-424.
-
(1983)
Acc. Chem. Res.
, vol.16
, pp. 418-424
-
-
Alston, T.A.1
Proter, D.J.T.2
Bright, H.J.3
-
122
-
-
0024501573
-
Molecular orbital calculations on tumor-inhibitory aniline mustards: QSARs
-
Lewis, D.F.V. (1989) Molecular orbital calculations on tumor-inhibitory aniline mustards: QSARs. Xenobiotica 19, 243-251.
-
(1989)
Xenobiotica
, vol.19
, pp. 243-251
-
-
Lewis, D.F.V.1
-
123
-
-
0025021102
-
Hypoxia-selective antitumor agents. 3. Relationships between structure and cytotoxicity against cultured tumor cells for substituted N,N-bis(2-chloroethyl)anilines
-
Palmer, B.D., Wilson, W.R., Pullen, S.M. and Denny, W.A. (1990) Hypoxia-selective antitumor agents. 3. Relationships between structure and cytotoxicity against cultured tumor cells for substituted N,N-bis(2-chloroethyl)anilines. J. Med. Chem. 33, 112-121.
-
(1990)
J. Med. Chem.
, vol.33
, pp. 112-121
-
-
Palmer, B.D.1
Wilson, W.R.2
Pullen, S.M.3
Denny, W.A.4
-
124
-
-
0026665360
-
Hypoxia-selective antitumor agents. 5. Synthesis of water-soluble nitroaniline mustards with selective cytotoxicity for hypoxic mammalian cells
-
Palmer, B.D., Wilson, W.R., Cliffe, S. and Denny, W.A. (1992) Hypoxia-selective antitumor agents. 5. Synthesis of water-soluble nitroaniline mustards with selective cytotoxicity for hypoxic mammalian cells. J. Med. Chem. 35, 3214-3222.
-
(1992)
J. Med. Chem.
, vol.35
, pp. 3214-3222
-
-
Palmer, B.D.1
Wilson, W.R.2
Cliffe, S.3
Denny, W.A.4
-
125
-
-
0025951037
-
Nitroheterocycle reduction as a paradigm for intramolecular catalysis of drug delivery to hypoxic cells
-
Firestone, A., Mulcahy, R.T. and Borch, R.F. (1991) Nitroheterocycle reduction as a paradigm for intramolecular catalysis of drug delivery to hypoxic cells. J. Med. Chem. 34, 2933-2935.
-
(1991)
J. Med. Chem.
, vol.34
, pp. 2933-2935
-
-
Firestone, A.1
Mulcahy, R.T.2
Borch, R.F.3
-
126
-
-
0028308246
-
Nitrobenzyl mustard quaternary salts: A new class of hypoxia-selective cytotoxins capable of releasing diffusible cytotoxins on bioreduction
-
Denny, W.A., Wilson, W.R., Tercel, M., Van Zijl, P. and Pullen, S.M. (1994) Nitrobenzyl mustard quaternary salts: a new class of hypoxia-selective cytotoxins capable of releasing diffusible cytotoxins on bioreduction. Int. J. Radiat. Oncol. Biol. Phys. 29, 317-321
-
(1994)
Int. J. Radiat. Oncol. Biol. Phys.
, vol.29
, pp. 317-321
-
-
Denny, W.A.1
Wilson, W.R.2
Tercel, M.3
Van Zijl, P.4
Pullen, S.M.5
-
127
-
-
0028292905
-
Relationships between structure and kinetics of cyclization of 2-aminoaryl amides: Potential prodrugs of cyclization-activated aromatic mustards
-
Atwell, G.J., Sykes, B.M., O'Connor, C.J. and Denny, W.A. (1994) Relationships between structure and kinetics of cyclization of 2-aminoaryl amides: potential prodrugs of cyclization-activated aromatic mustards. J. Med. Chem. 37, 371-380.
-
(1994)
J. Med. Chem.
, vol.37
, pp. 371-380
-
-
Atwell, G.J.1
Sykes, B.M.2
O'Connor, C.J.3
Denny, W.A.4
-
128
-
-
0021971997
-
Porfiromycin as a bioreductive alkylating agent with selective toxicity to hypoxic EMT6 tumor cells in vivo and in vitro
-
Keyes, S.R., Rockwell, S. and Sartorelli, A.C. (1985) Porfiromycin as a bioreductive alkylating agent with selective toxicity to hypoxic EMT6 tumor cells in vivo and in vitro. Cancer Res. 45, 3642-3645.
-
(1985)
Cancer Res.
, vol.45
, pp. 3642-3645
-
-
Keyes, S.R.1
Rockwell, S.2
Sartorelli, A.C.3
-
129
-
-
0023774903
-
Modulation of the cytotoxicity of mitomycin C to EMT6 mouse mammary tumors by dicoumarol in vitro
-
Rockwell, S., Keyes, S.R. and Sartorelli, A.C. (1988) Modulation of the cytotoxicity of mitomycin C to EMT6 mouse mammary tumors by dicoumarol in vitro. Cancer Res. 48, 5471-5474.
-
(1988)
Cancer Res.
, vol.48
, pp. 5471-5474
-
-
Rockwell, S.1
Keyes, S.R.2
Sartorelli, A.C.3
-
130
-
-
0025893246
-
The role of NAD(P)H: Quinone reductase (EC 1.6.99.2, DT-diaphorase) in the reductive bioactivation of the novel indoloquinone antitumor agent EO9
-
Walton, M.I., Smith, P.J. and Workman, P. (1991) The role of NAD(P)H: quinone reductase (EC 1.6.99.2, DT-diaphorase) in the reductive bioactivation of the novel indoloquinone antitumor agent EO9. Cancer Commun. 3, 199-206.
-
(1991)
Cancer Commun.
, vol.3
, pp. 199-206
-
-
Walton, M.I.1
Smith, P.J.2
Workman, P.3
-
131
-
-
0025797202
-
Chinese hamster ovary cell lines resistant to mitomycin C under aerobic but not hypoxic conditions are deficient in DT diaphorase
-
Dulhanty, A.M. and Whitmore, G.F. (1991) Chinese hamster ovary cell lines resistant to mitomycin C under aerobic but not hypoxic conditions are deficient in DT diaphorase. Cancer Res. 51, 1860-1865.
-
(1991)
Cancer Res.
, vol.51
, pp. 1860-1865
-
-
Dulhanty, A.M.1
Whitmore, G.F.2
-
132
-
-
0001464558
-
Reductive lactonization of strategically methylated quinone propionic acid esters and amides
-
Carpino, L.A., Triolo, S.A. and Berglund, R.A. (1988) Reductive lactonization of strategically methylated quinone propionic acid esters and amides. J. Org. Chem. 54, 3303-3310.
-
(1988)
J. Org. Chem.
, vol.54
, pp. 3303-3310
-
-
Carpino, L.A.1
Triolo, S.A.2
Berglund, R.A.3
-
133
-
-
0015526371
-
Stereopopulation control. I. Rate enhancement in the lactonizations of o-hydroxyhydrocinnamic acids
-
Milstien, S. and Cohen, L.A. (1972) Stereopopulation control. I. Rate enhancement in the lactonizations of o-hydroxyhydrocinnamic acids. J. Am. Chem. Soc. 94, 9158-9165.
-
(1972)
J. Am. Chem. Soc.
, vol.94
, pp. 9158-9165
-
-
Milstien, S.1
Cohen, L.A.2
-
134
-
-
0015526361
-
Stereopopulation control. II. Rate enhancement of intramolecular nucleophilic displacement
-
Borchardt, R.T. and Cohen, L.A. (1972) Stereopopulation control. II. Rate enhancement of intramolecular nucleophilic displacement. J. Am. Chem. Soc. 94, 9166-9174.
-
(1972)
J. Am. Chem. Soc.
, vol.94
, pp. 9166-9174
-
-
Borchardt, R.T.1
Cohen, L.A.2
-
135
-
-
0015526376
-
Stereopopulation control. III. Facilitation of intramolecular conjugate addition of the carboxyl group
-
Borchardt, R.T. and Cohen, L.A. (1972) Stereopopulation control. III. Facilitation of intramolecular conjugate addition of the carboxyl group. J. Am. Chem. Soc. 94, 9175-9182.
-
(1972)
J. Am. Chem. Soc.
, vol.94
, pp. 9175-9182
-
-
Borchardt, R.T.1
Cohen, L.A.2
-
136
-
-
0000160051
-
Correlation of reaction rate acceleration with rotational restriction. Crystal structure analysis of compounds with a trialkyl lock
-
Karle, J.M. and Karle, I.L. (1972) Correlation of reaction rate acceleration with rotational restriction. Crystal structure analysis of compounds with a trialkyl lock. J. Am. Chem. Soc. 94, 9182-9189.
-
(1972)
J. Am. Chem. Soc.
, vol.94
, pp. 9182-9189
-
-
Karle, J.M.1
Karle, I.L.2
-
137
-
-
0000492812
-
Formation and hydrolysis of lactones of phenolic acids
-
Caswell, M. and Schmir, G.L. (1980) Formation and hydrolysis of lactones of phenolic acids. J. Am. Chem. Soc. 102, 4815-4821.
-
(1980)
J. Am. Chem. Soc.
, vol.102
, pp. 4815-4821
-
-
Caswell, M.1
Schmir, G.L.2
-
138
-
-
0025869654
-
Amine prodrugs which utilize hydroxy amide lactonization. I. A potential redox-sensitive amide prodrug
-
Amsberry, K.L. and Borchardt, R.T. (1991) Amine prodrugs which utilize hydroxy amide lactonization. I. A potential redox-sensitive amide prodrug. Pharm. Res. 8, 323-330.
-
(1991)
Pharm. Res.
, vol.8
, pp. 323-330
-
-
Amsberry, K.L.1
Borchardt, R.T.2
-
139
-
-
0027220811
-
Rationale for the use of aliphatic N-oxides of cytotoxic anthraquinones as prodrug DNA binding agents: A new class of bioreductive agent
-
Patterson, L.H. (1993) Rationale for the use of aliphatic N-oxides of cytotoxic anthraquinones as prodrug DNA binding agents: a new class of bioreductive agent. Cancer Metastasis Rev. 12, 119-134.
-
(1993)
Cancer Metastasis Rev.
, vol.12
, pp. 119-134
-
-
Patterson, L.H.1
-
140
-
-
0024427760
-
Reduction of nitromin to nitrogen mustard: Unscheduled DNA synthesis in aerobic or anaerobic rat hepatocytes, JB1, BL8 and Walker carcinoma cell lines
-
White, I.N.H., Suzanger, M., Mattocks, A.R., Bailey, E., Farmer, P.B., Connors, T.A. (1989) Reduction of nitromin to nitrogen mustard: unscheduled DNA synthesis in aerobic or anaerobic rat hepatocytes, JB1, BL8 and Walker carcinoma cell lines. Carcinogenesis 10, 2113-2118.
-
(1989)
Carcinogenesis
, vol.10
, pp. 2113-2118
-
-
White, I.N.H.1
Suzanger, M.2
Mattocks, A.R.3
Bailey, E.4
Farmer, P.B.5
Connors, T.A.6
-
141
-
-
37049083007
-
Synthesis of novel N-and S-mustards as potential pro-drugs activated by bioreductive processes
-
Mann, J., Shervington, L.A. (1991) Synthesis of novel N-and S-mustards as potential pro-drugs activated by bioreductive processes. J. Chem. Soc. Perkin Trans. I 2961-2964.
-
(1991)
J. Chem. Soc. Perkin Trans.
, vol.1
, pp. 2961-2964
-
-
Mann, J.1
Shervington, L.A.2
-
142
-
-
0022493495
-
SR 4233: A new bioreductive agent with high selective toxicity for hypoxic mammalian cells
-
Zeman, E.M., Brown, J.M., Lemmon, M.J., Hirst, V.K., Lee, W.W. (1986) SR 4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells. Int. J. Radiat. Oncol. Biol. Phys. 12, 1239-1242.
-
(1986)
Int. J. Radiat. Oncol. Biol. Phys.
, vol.12
, pp. 1239-1242
-
-
Zeman, E.M.1
Brown, J.M.2
Lemmon, M.J.3
Hirst, V.K.4
Lee, W.W.5
-
143
-
-
0027931173
-
Reduction of 3-amino-1,2,4-benzotriazine-1,4-di-N-oxide (tirapazamine, WIN 59075, SR 4233) to a DNA-damaging species: A direct role for NADPH:Cytochrome P450 oxidoreductase
-
Fitzsimmons, S.A., Lewis, A.D. Riley, R.J. and Workman, P. (1994) Reduction of 3-amino-1,2,4-benzotriazine-1,4-di-N-oxide (tirapazamine, WIN 59075, SR 4233) to a DNA-damaging species: a direct role for NADPH:cytochrome P450 oxidoreductase. Carcinogenesis 15, 1503-1510.
-
(1994)
Carcinogenesis
, vol.15
, pp. 1503-1510
-
-
Fitzsimmons, S.A.1
Lewis, A.D.2
Riley, R.J.3
Workman, P.4
-
144
-
-
0026047102
-
Microsomal reduction of 3-amino-1,2,4-benzotriazene 1,4-dioxide to a free radical
-
Lloyd, R.V., Duling, D.R., Rumyantseva, G.V., Mason, R.P. and Bridson, P.K. (1991). Microsomal reduction of 3-amino-1,2,4-benzotriazene 1,4-dioxide to a free radical. Mol. Pharmacol. 40, 440-445.
-
(1991)
Mol. Pharmacol.
, vol.40
, pp. 440-445
-
-
Lloyd, R.V.1
Duling, D.R.2
Rumyantseva, G.V.3
Mason, R.P.4
Bridson, P.K.5
-
145
-
-
0017282490
-
Reduction of tertiary amine N-oxids by microsomal cytochrome P450
-
Suguira, M., Iwasaki, K. and Kato, R. (1976) Reduction of tertiary amine N-oxids by microsomal cytochrome P450. Mol. Pharmacol. 12, 322-334.
-
(1976)
Mol. Pharmacol.
, vol.12
, pp. 322-334
-
-
Suguira, M.1
Iwasaki, K.2
Kato, R.3
-
146
-
-
0025073825
-
Reductive metabolism of 3-amino-1,2,4-benzotriazene-1,4-dioxide (SR4233) and the induction of unscheduled DNA synthesis in rat and human derived cell lines
-
Cahill, A. and White, I.N.H. (1990) Reductive metabolism of 3-amino-1,2,4-benzotriazene-1,4-dioxide (SR4233) and the induction of unscheduled DNA synthesis in rat and human derived cell lines. Carcinogenesis 11, 1407-1411.
-
(1990)
Carcinogenesis
, vol.11
, pp. 1407-1411
-
-
Cahill, A.1
White, I.N.H.2
-
147
-
-
0023689603
-
Metabolism of SR 4233 by Chinese hamster ovary cells: Basis of selective hypoxic cyjtotoxicity
-
Baker, M.A., Zeman, E.M., Hirst, V.K. and Brown. J.M. (1988) Metabolism of SR 4233 by Chinese hamster ovary cells: basis of selective hypoxic cyjtotoxicity. Cancer Res. 48, 5947-5952.
-
(1988)
Cancer Res.
, vol.48
, pp. 5947-5952
-
-
Baker, M.A.1
Zeman, E.M.2
Hirst, V.K.3
Brown, J.M.4
-
148
-
-
0027418726
-
Metabolism of the bioreductive cytotoxin SR 4233 by tumor cells: Enzymatic studies
-
Wang, J., Biedermann, K.A., Wolf, C.R. and Brown, J.M. (1993) Metabolism of the bioreductive cytotoxin SR 4233 by tumor cells: enzymatic studies. Br. J. Cancer 67, 321-325.
-
(1993)
Br. J. Cancer
, vol.67
, pp. 321-325
-
-
Wang, J.1
Biedermann, K.A.2
Wolf, C.R.3
Brown, J.M.4
-
149
-
-
0024532975
-
In vitro hepatotoxicity of SR 4233 (3-amino-1,2,4-benzotriazene-1,4-di-oxide), a hypoxic cytotoxin and potential antitumor agent
-
Costa, A.K., Baker, M.A., Brown, J.M. and Truddell, J.R. (1989) In vitro hepatotoxicity of SR 4233 (3-amino-1,2,4-benzotriazene-1,4-di-oxide), a hypoxic cytotoxin and potential antitumor agent. Cancer Res. 49, 925-929.
-
(1989)
Cancer Res.
, vol.49
, pp. 925-929
-
-
Costa, A.K.1
Baker, M.A.2
Brown, J.M.3
Truddell, J.R.4
-
150
-
-
0025308187
-
The effects of three bioreductive drugs (mitomycin C, RSU 1069, and SR 4233) on cell lines selected for their sensitivity to mitomycin C or ionising radiation
-
Kohane, A., Godden, J., Stratford, I.J. and Adams, G.E. (1990) The effects of three bioreductive drugs (mitomycin C, RSU 1069, and SR 4233) on cell lines selected for their sensitivity to mitomycin C or ionising radiation. Br. J. Cancer 61, 722-726.
-
(1990)
Br. J. Cancer
, vol.61
, pp. 722-726
-
-
Kohane, A.1
Godden, J.2
Stratford, I.J.3
Adams, G.E.4
-
151
-
-
0026073332
-
SR4233 cytotoxicity and metabolism in DNA repair-competent and repair-deficient cell cultures
-
Biederman, K.A., Wang, J. Graham, R.P. and Brown, J.M. (1991) SR4233 cytotoxicity and metabolism in DNA repair-competent and repair-deficient cell cultures. Br. J. Cancer 63, 358-362.
-
(1991)
Br. J. Cancer
, vol.63
, pp. 358-362
-
-
Biederman, K.A.1
Wang, J.2
Graham, R.P.3
Brown, J.M.4
-
152
-
-
0024414046
-
The differntial hypoxic cytotoxicity of bioreductive agents determined in vitro by the MTT assay
-
Stratford, I.J. and Stephens, M.A. (1989) The differntial hypoxic cytotoxicity of bioreductive agents determined in vitro by the MTT assay. Int. J. Radiat. Oncol. Biol. Phys. 16, 973-976.
-
(1989)
Int. J. Radiat. Oncol. Biol. Phys.
, vol.16
, pp. 973-976
-
-
Stratford, I.J.1
Stephens, M.A.2
-
153
-
-
0028961623
-
Fused pyrazine mono-N-oxides as bioreductive drugs III. Characterization of RB 90740 in vitro and in vivo
-
Naylor, M.A., Adams, G.E., Haigh, A., Cole, S. Jenner, T., Robertson, N, Siemann, D., Stephens, M.A. and Stratford, I.J. (1995) Fused pyrazine mono-N-oxides as bioreductive drugs III. Characterization of RB 90740 in vitro and in vivo. Anti-Cancer Drugs 6, 259-269.
-
(1995)
Anti-cancer Drugs
, vol.6
, pp. 259-269
-
-
Naylor, M.A.1
Adams, G.E.2
Haigh, A.3
Cole, S.4
Jenner, T.5
Robertson, N.6
Siemann, D.7
Stephens, M.A.8
Stratford, I.J.9
-
154
-
-
0029027637
-
Hypoxia-selective agents derived from quinoxaline 1,4-di-N-oxides
-
Monge, A., Palop, J.A., de Cerain, A.L., Senador, V., Martinez-Crespo, F.J., Sainz, Y., Narro, S., Garcia, E., de Miguel, C., Gonzalez, M., Hamilton, E., Barker, A.J., Clarke, E.D. and Greenhow, D.T. (1995) Hypoxia-selective agents derived from quinoxaline 1,4-di-N-oxides. J. Med Chem. 38, 1786-1792.
-
(1995)
J. Med Chem.
, vol.38
, pp. 1786-1792
-
-
Monge, A.1
Palop, J.A.2
De Cerain, A.L.3
Senador, V.4
Martinez-Crespo, F.J.5
Sainz, Y.6
Narro, S.7
Garcia, E.8
De Miguel, C.9
Gonzalez, M.10
Hamilton, E.11
Barker, A.J.12
Clarke, E.D.13
Greenhow, D.T.14
-
155
-
-
0018250764
-
Drug latentiation in cancer chemotherapy
-
Workman and Double, J.A. (1978) Drug latentiation in cancer chemotherapy. Biomedicine 28, 2555-2562.
-
(1978)
Biomedicine
, vol.28
, pp. 2555-2562
-
-
Workman1
Double, J.A.2
-
157
-
-
0017845325
-
Inhibition of human prostatic tumor acid phosphatase by N,N-p-di-2-chloroethylaminophenol, N,N-p-di-2-chloroethylaminophenyl phosphate and other difunctional nitrogen mustards
-
Workman, P. (1978) Inhibition of human prostatic tumor acid phosphatase by N,N-p-di-2-chloroethylaminophenol, N,N-p-di-2-chloroethylaminophenyl phosphate and other difunctional nitrogen mustards. Chem-Biol. Interact. 20, 103-112.
-
(1978)
Chem-Biol. Interact.
, vol.20
, pp. 103-112
-
-
Workman, P.1
-
159
-
-
0019860703
-
An examination of the relative resistances to aflatoxin B1 and susceptibilities to gamma-glutamyltransferase negative and positive cell lines
-
Manson M.M., Legg R.F., Watson J.V., Green J.A. and Neal G.E. (1981) An examination of the relative resistances to aflatoxin B1 and susceptibilities to gamma-glutamyltransferase negative and positive cell lines. Carcinogenesis 2, 661-670.
-
(1981)
Carcinogenesis
, vol.2
, pp. 661-670
-
-
Manson, M.M.1
Legg, R.F.2
Watson, J.V.3
Green, J.A.4
Neal, G.E.5
-
160
-
-
0022576114
-
Prodrugs in cancer chemotherapy
-
Wilman, D.E.V. (1986) Prodrugs in cancer chemotherapy. Biochem. Soc. Trans. 14, 375-382.
-
(1986)
Biochem. Soc. Trans.
, vol.14
, pp. 375-382
-
-
Wilman, D.E.V.1
-
161
-
-
0014024073
-
Cure of mice bearng advanced plasma cell tumours with aniline mustard: The relationship between glucuronidase activity and tumour sensitivity
-
Connors, T.A. and Whisson, M.E. (1966) Cure of mice bearng advanced plasma cell tumours with aniline mustard: The relationship between glucuronidase activity and tumour sensitivity. Nature 210, 866-867.
-
(1966)
Nature
, vol.210
, pp. 866-867
-
-
Connors, T.A.1
Whisson, M.E.2
-
162
-
-
0002377785
-
Reduction of cytotoxic azo compounds by hydrazine and by the xanthine oxidase-xanthine system
-
Ross, W. C. J. and Warwick, G. P. (1955) Reduction of cytotoxic azo compounds by hydrazine and by the xanthine oxidase-xanthine system. Nature 176, 298-299.
-
(1955)
Nature
, vol.176
, pp. 298-299
-
-
Ross, W.C.J.1
Warwick, G.P.2
-
163
-
-
0142192711
-
Aryl-2-halogenoalkylamines. Part XVI. The preparation of 4-[di-(2-chloroalkyl)amino]azobenzenes
-
Ross, W.C.J. and Warwick, G. P. (1956) Aryl-2-halogenoalkylamines. Part XVI. The preparation of 4-[di-(2-chloroalkyl)amino]azobenzenes. J. Chem. Soc. 1364-1369.
-
(1956)
J. Chem. Soc.
, pp. 1364-1369
-
-
Ross, W.C.J.1
Warwick, G.P.2
-
164
-
-
0015546512
-
Cytotoxic agents designed to be selective for liver cancer
-
Bukhari, M.A., Connors, T.A., Gilsenan, A.M., Ross, W.C.J., Tisdale, M.J., Warwick, G.P. and Wilman, D.E.V. (1973) Cytotoxic agents designed to be selective for liver cancer. J. Natl. Cancer Inst. 50, 243-247.
-
(1973)
J. Natl. Cancer Inst.
, vol.50
, pp. 243-247
-
-
Bukhari, M.A.1
Connors, T.A.2
Gilsenan, A.M.3
Ross, W.C.J.4
Tisdale, M.J.5
Warwick, G.P.6
Wilman, D.E.V.7
-
165
-
-
0343314134
-
Agents designed specifically for the treatement of liver cancer
-
Garattini, S. and Franchi, G. (Eds), Raven Press, New York
-
Connors, T.A., Gilsenan, A. M., Ross, W. C. J., Bukhari, A., Tisdale, M. J. and Warwick, G. P. (1973) Agents designed specifically for the treatement of liver cancer. In: Garattini, S. and Franchi, G. (Eds), Chemotherapy of Cancer Dissemination and Metastasis, Raven Press, New York, pp. 367-376.
-
(1973)
Chemotherapy of Cancer Dissemination and Metastasis
, pp. 367-376
-
-
Connors, T.A.1
Gilsenan, A.M.2
Ross, W.C.J.3
Bukhari, A.4
Tisdale, M.J.5
Warwick, G.P.6
-
167
-
-
0015867805
-
High-dose diethylstilbesterol therapy of prostate cancer after failure of standard doses of oestrogens
-
Band, P.R., Banerjee, T.K., Patwardhan, V.C. and Eid, J.C. (1973) High-dose diethylstilbesterol therapy of prostate cancer after failure of standard doses of oestrogens. Cancer Med. Assoc. J. 109, 697-699.
-
(1973)
Cancer Med. Assoc. J.
, vol.109
, pp. 697-699
-
-
Band, P.R.1
Banerjee, T.K.2
Patwardhan, V.C.3
Eid, J.C.4
-
168
-
-
0016432718
-
Oral estramustine phosphate (NSX-89199) in the treatment of advanced (stage D) carcinoma of the prostate
-
Mittleman, A., Shukla, S.K., Welwaart, K. and Murphy, G.P. (1975) Oral estramustine phosphate (NSX-89199) in the treatment of advanced (stage D) carcinoma of the prostate. Cancer Chemother. Rep. 59, 219-223.
-
(1975)
Cancer Chemother. Rep.
, vol.59
, pp. 219-223
-
-
Mittleman, A.1
Shukla, S.K.2
Welwaart, K.3
Murphy, G.P.4
-
169
-
-
0017397510
-
A new high-glucuronidase mouse tumour curable by aniline mustard therapy
-
Double, J.A. and Workman, P.A. (1977) A new high-glucuronidase mouse tumour curable by aniline mustard therapy. Cancer Treat. Rep. 61, 909-911.
-
(1977)
Cancer Treat. Rep.
, vol.61
, pp. 909-911
-
-
Double, J.A.1
Workman, P.A.2
-
170
-
-
0015813383
-
Metabolism of aniline mustard [N,N-di-(2-chloroethyl)aniline]
-
Connors, T.A., Farmer, P.B., Foster, A.B., Gilsenan, A.M., Jarman, M and Tisdale, M.J. (1973) Metabolism of aniline mustard [N,N-di-(2-chloroethyl)aniline]. Biochem. Pharmacol. 22, 1971-1980.
-
(1973)
Biochem. Pharmacol.
, vol.22
, pp. 1971-1980
-
-
Connors, T.A.1
Farmer, P.B.2
Foster, A.B.3
Gilsenan, A.M.4
Jarman, M.5
Tisdale, M.J.6
-
171
-
-
0017167325
-
Therapeutic trial of aniline mustard in patients with advanced cancer. Comparison of therapeutic response with cytochemical assessment of tumor cell β-glucuronidase activity
-
Young, C.W., Yogoda, A., Bitlar, E.S., Smith, S.W., Grabstald, H. and Whitmore, W. (1976) Therapeutic trial of aniline mustard in patients with advanced cancer. Comparison of therapeutic response with cytochemical assessment of tumor cell β-glucuronidase activity. Cancer 38, 1887-1895.
-
(1976)
Cancer
, vol.38
, pp. 1887-1895
-
-
Young, C.W.1
Yogoda, A.2
Bitlar, E.S.3
Smith, S.W.4
Grabstald, H.5
Whitmore, W.6
-
172
-
-
0017604857
-
Gamma-glutamyltransferase levels in ascitic fluid and liver tissue from patients with primary hepatoma
-
Peters, T.J., Seymour, C.A., Wells, G., Fakunle, F. and Neale, G. (1977) Gamma-glutamyltransferase levels in ascitic fluid and liver tissue from patients with primary hepatoma. Br. Med. J. Part I, 1576.
-
(1977)
Br. Med. J. Part I
, pp. 1576
-
-
Peters, T.J.1
Seymour, C.A.2
Wells, G.3
Fakunle, F.4
Neale, G.5
-
173
-
-
0028174228
-
γ-Glutamyltranspeptidase expression regulates the growth-inhibitory activity of the anti-tumor prodrug γ-L-glutaminyl-4-hydroxy-3-iodobenzene
-
Prezioso, J.A., Hughey, R.P., Wang, N., Damodaran, K.M. and Bloomer, W.D. (1994) γ-Glutamyltranspeptidase expression regulates the growth-inhibitory activity of the anti-tumor prodrug γ-L-glutaminyl-4-hydroxy-3-iodobenzene. Int. J. Cancer 56, 874-879.
-
(1994)
Int. J. Cancer
, vol.56
, pp. 874-879
-
-
Prezioso, J.A.1
Hughey, R.P.2
Wang, N.3
Damodaran, K.M.4
Bloomer, W.D.5
-
174
-
-
0020607978
-
Plasmin-activated prodrugs for cancer chemotherapy. 1. Synthesis and biological activity of peptidylacivicin and peptidylphenylenediamine mustard
-
Chakravarty, P.K., Carl, P.L., Weber, M.J. and Katzenellenbogen, J.A. (1983) Plasmin-activated prodrugs for cancer chemotherapy. 1. Synthesis and biological activity of peptidylacivicin and peptidylphenylenediamine mustard. J. Med. Chem. 26. 633-638.
-
(1983)
J. Med. Chem.
, vol.26
, pp. 633-638
-
-
Chakravarty, P.K.1
Carl, P.L.2
Weber, M.J.3
Katzenellenbogen, J.A.4
-
175
-
-
0020644940
-
Plasmin-activated prodrugs for cancer chemotherapy. 2. Synthesis and biological activity of peptidyl derivatives of doxorubicin
-
Chakravarty, P.K., Carl, P.L., Weber, M.J. and Katzenellenbogen, J.A. (1983) Plasmin-activated prodrugs for cancer chemotherapy. 2. Synthesis and biological activity of peptidyl derivatives of doxorubicin. J. Med. Chem. 26, 638-644.
-
(1983)
J. Med. Chem.
, vol.26
, pp. 638-644
-
-
Chakravarty, P.K.1
Carl, P.L.2
Weber, M.J.3
Katzenellenbogen, J.A.4
-
176
-
-
0014007589
-
pH studies in human malignant tumours
-
Ashby, B.S. (1966) pH studies in human malignant tumours. Lancet 2, 312-315.
-
(1966)
Lancet
, vol.2
, pp. 312-315
-
-
Ashby, B.S.1
-
177
-
-
0343749880
-
Experimental studies on cancer. I. The influence of patenteral administration of certain sugars on the pH of malignant tumours
-
Voegtlin, C., Fitch, R.H., Kahler, H., Johnson, J.M. and Thomson, J.W. (1935) Experimental studies on cancer. I. The influence of patenteral administration of certain sugars on the pH of malignant tumours. Natl. Inst. Health Bull. 164, 1-14.
-
(1935)
Natl. Inst. Health Bull.
, vol.164
, pp. 1-14
-
-
Voegtlin, C.1
Fitch, R.H.2
Kahler, H.3
Johnson, J.M.4
Thomson, J.W.5
-
178
-
-
0014098952
-
Glucose consumption by transplanted tumors in vivo
-
Gullino, P.M., Grantham, F.H. and Courtney, A.H. (1967) Glucose consumption by transplanted tumors in vivo. Cancer Res. 27, 1031-1040.
-
(1967)
Cancer Res.
, vol.27
, pp. 1031-1040
-
-
Gullino, P.M.1
Grantham, F.H.2
Courtney, A.H.3
-
179
-
-
0020030456
-
Tumor-selective modification of cellular microenvironment in vivo: Effect of glucose infusion on the pH in normal and malignant rat tissues
-
Jahde, E. and Rajewsky, M.F. (1982) Tumor-selective modification of cellular microenvironment in vivo: effect of glucose infusion on the pH in normal and malignant rat tissues. Cancer Res. 42, 1505-1512.
-
(1982)
Cancer Res.
, vol.42
, pp. 1505-1512
-
-
Jahde, E.1
Rajewsky, M.F.2
-
180
-
-
77956791953
-
Taxol: From discovery to therapeutic use
-
Suffness, M. (1993) Taxol: from discovery to therapeutic use. Ann. Rep. Med. Chem. 28, 305-314.
-
(1993)
Ann. Rep. Med. Chem.
, vol.28
, pp. 305-314
-
-
Suffness, M.1
-
181
-
-
0024597827
-
Synthesis of congeners and prodrugs, 3. Water-soluble prodrugs of taxol with potent antitumor activity
-
Deutsch, H.M., Hernandez, M., Haugwitz, R.D., Narayanan, V.L., Suffness, M. and Zalkow, L.H. (1989) Synthesis of congeners and prodrugs, 3. Water-soluble prodrugs of taxol with potent antitumor activity. J. Med. Chem. 32, 788-792.
-
(1989)
J. Med. Chem.
, vol.32
, pp. 788-792
-
-
Deutsch, H.M.1
Hernandez, M.2
Haugwitz, R.D.3
Narayanan, V.L.4
Suffness, M.5
Zalkow, L.H.6
-
182
-
-
0026317822
-
Modified taxols, 6. Preparation of water-soluble prodrugs of taxol
-
Zhao, Z. and Kingston, D.G.I. (1991) Modified taxols, 6. preparation of water-soluble prodrugs of taxol. J. Natural Prod. 54, 1607-1611.
-
(1991)
J. Natural Prod.
, vol.54
, pp. 1607-1611
-
-
Zhao, Z.1
Kingston, D.G.I.2
-
183
-
-
0026567883
-
Synthesis and evaluation of some water soluble prodrugs and derivatives of taxol with antitumor activity
-
Mathew, A.E., Mejillano, M.R., Nath, J.P., Himes, R.H. and Stella, V.J. (1992) Synthesis and evaluation of some water soluble prodrugs and derivatives of taxol with antitumor activity. J. Med. Chem. 35, 145-151.
-
(1992)
J. Med. Chem.
, vol.35
, pp. 145-151
-
-
Mathew, A.E.1
Mejillano, M.R.2
Nath, J.P.3
Himes, R.H.4
Stella, V.J.5
-
184
-
-
0027258227
-
Design, sythesis and biological activity of protaxols
-
Nicolaou, K.C., Riemer, C., Kerr, M.A., Rideout, D. and Wrasidlo, W. (1993) Design, sythesis and biological activity of protaxols. Nature 364, 464-466.
-
(1993)
Nature
, vol.364
, pp. 464-466
-
-
Nicolaou, K.C.1
Riemer, C.2
Kerr, M.A.3
Rideout, D.4
Wrasidlo, W.5
-
185
-
-
0028062072
-
Highly water soluble taxol derivatives: 2-polyethyleneglycol esters as potential prodrugs
-
Greenwald, R.B., Pendri, A., Bolikal, D. and Gilbert, C.W. (1994) Highly water soluble taxol derivatives: 2-polyethyleneglycol esters as potential prodrugs. Bioorg. Med. Chem. Lett. 4, 2465-2470.
-
(1994)
Bioorg. Med. Chem. Lett.
, vol.4
, pp. 2465-2470
-
-
Greenwald, R.B.1
Pendri, A.2
Bolikal, D.3
Gilbert, C.W.4
-
186
-
-
0027273772
-
Synthesis and antitumor evaluation of water slouble taxol phosphates
-
Vyas, D.M., Wong, H., Crosswell, A.R., Casazza, A.M., Knipe, J.O., Mamber, S.W. and Doyle, T.W. (1993) Synthesis and antitumor evaluation of water slouble taxol phosphates. Bioorg. Med. Chem. Lett. 3, 1357-1360.
-
(1993)
Bioorg. Med. Chem. Lett.
, vol.3
, pp. 1357-1360
-
-
Vyas, D.M.1
Wong, H.2
Crosswell, A.R.3
Casazza, A.M.4
Knipe, J.O.5
Mamber, S.W.6
Doyle, T.W.7
-
187
-
-
0027290772
-
Novel water soluble phosphate prodrugs of taxol possessing in vivo antitumor activity
-
Ueda, Y., Mikkilineni, A.B., Knipe, J.O., Rose, W.C., Casazza, A.M. and Vyas, D.M. (1993) Novel water soluble phosphate prodrugs of taxol possessing in vivo antitumor activity. Bioorg. Med. Chem. Lett. 3, 1761-1766.
-
(1993)
Bioorg. Med. Chem. Lett.
, vol.3
, pp. 1761-1766
-
-
Ueda, Y.1
Mikkilineni, A.B.2
Knipe, J.O.3
Rose, W.C.4
Casazza, A.M.5
Vyas, D.M.6
-
188
-
-
0021962185
-
Etoposide (VP-16-213): Current status of an active anticancer drug
-
O'Dwyer, P.L., Leyland-Jones, B., Alonso, M.T., Marsoni, S. and Wittes, R.E. (1985) Etoposide (VP-16-213): current status of an active anticancer drug. N. Engl. J. Med. 312, 692-700.
-
(1985)
N. Engl. J. Med.
, vol.312
, pp. 692-700
-
-
O'Dwyer, P.L.1
Leyland-Jones, B.2
Alonso, M.T.3
Marsoni, S.4
Wittes, R.E.5
-
189
-
-
0028020863
-
Phase I evaluation of a water-soluble etoposide prodrug, etoposide phosphate, given as a 5-minute infusion on days 1, 3, and 5 in patients with solid tumors
-
Budman, D.R., Igwemezie, L.N., Kaul, S., Behr, J., Lichtman, S., Schulman, P., Vinciguerra, V., Allen, S.L., Kolitz, J., Hock, K., O'Neill, K., Schacter, L. and Barbhaiya, R.H. (1994) Phase I evaluation of a water-soluble etoposide prodrug, etoposide phosphate, given as a 5-minute infusion on days 1, 3, and 5 in patients with solid tumors. J. Clin. Oncol. 12, 1902-1909.
-
(1994)
J. Clin. Oncol.
, vol.12
, pp. 1902-1909
-
-
Budman, D.R.1
Igwemezie, L.N.2
Kaul, S.3
Behr, J.4
Lichtman, S.5
Schulman, P.6
Vinciguerra, V.7
Allen, S.L.8
Kolitz, J.9
Hock, K.10
O'Neill, K.11
Schacter, L.12
Barbhaiya, R.H.13
-
191
-
-
0028029894
-
Sythesis of etoposide phosphate, bmy-40481: A water-soluble clinically active prodrug of etoposide
-
Saulnier, M.G., Langley, D.R., Kadow, J.F., Senter, P.D., Knipe, J.O., Tun, M.M., Vyas, D.M. and Doyle, T.W. (1994) Sythesis of etoposide phosphate, bmy-40481: a water-soluble clinically active prodrug of etoposide. Bioorg. Med. Chem. Lett. 4, 2567-2572.
-
(1994)
Bioorg. Med. Chem. Lett.
, vol.4
, pp. 2567-2572
-
-
Saulnier, M.G.1
Langley, D.R.2
Kadow, J.F.3
Senter, P.D.4
Knipe, J.O.5
Tun, M.M.6
Vyas, D.M.7
Doyle, T.W.8
-
192
-
-
0025338153
-
Preclinical antitumor activity of a soluble etoposide analog, BMY-40481-30
-
Rose, W.C., Basler, G.A., Trail, P.A., Saulnier, M., Crosswell, A.R. and Casazza, A.M. (1990) Preclinical antitumor activity of a soluble etoposide analog, BMY-40481-30. Invest. New Drugs 8, S25-S32.
-
(1990)
Invest. New Drugs
, vol.8
-
-
Rose, W.C.1
Basler, G.A.2
Trail, P.A.3
Saulnier, M.4
Crosswell, A.R.5
Casazza, A.M.6
-
194
-
-
0028115928
-
Dose-dependent pharmacokinetics of rapamycin-28-N,N-dimethylglycinate in the mouse
-
Supko, J.G. and Malspeis, L. (1994) Dose-dependent pharmacokinetics of rapamycin-28-N,N-dimethylglycinate in the mouse. Cancer Chemother. Pharmacol. 33, 325-330.
-
(1994)
Cancer Chemother. Pharmacol.
, vol.33
, pp. 325-330
-
-
Supko, J.G.1
Malspeis, L.2
-
195
-
-
0027172492
-
N-Phosphoryl derivatives of bisantrene. Antitumor prodrugs with enhanced solubility and reduced potential for toxicity
-
Murdock, K.C., Lee, V.J., Citarella, R.V., Durr, F.E., Nicolau, G. and Kohlbrenner, M. (1993) N-Phosphoryl derivatives of bisantrene. Antitumor prodrugs with enhanced solubility and reduced potential for toxicity. J. Med. Chem. 36, 2098-2101.
-
(1993)
J. Med. Chem.
, vol.36
, pp. 2098-2101
-
-
Murdock, K.C.1
Lee, V.J.2
Citarella, R.V.3
Durr, F.E.4
Nicolau, G.5
Kohlbrenner, M.6
-
196
-
-
0022626910
-
Blood-brain barrier: Interface between medicine and the brain
-
Pardridge, W.M., Oldendorf, W., Cancilla, P. and Frank, H. (1986) Blood-brain barrier: interface between medicine and the brain. Ann. Int. Med. 105, 82-95.
-
(1986)
Ann. Int. Med.
, vol.105
, pp. 82-95
-
-
Pardridge, W.M.1
Oldendorf, W.2
Cancilla, P.3
Frank, H.4
-
198
-
-
0011229610
-
The blood-brain barrier. A modified tight epithelium
-
Suckling, A.J., Rumsby, M.G. and Bradbury, M.W.B. (Eds), Ellis Harwood, Chichester, UK
-
Crone, C. (1986) The blood-brain barrier. A modified tight epithelium. In: Suckling, A.J., Rumsby, M.G. and Bradbury, M.W.B. (Eds), The Blood-Brain Barrier in Health and Disease. Ellis Harwood, Chichester, UK.
-
(1986)
The Blood-brain Barrier in Health and Disease
-
-
Crone, C.1
-
199
-
-
0021800252
-
Prodrugs, do they have advantages in clinical practice?
-
Stella, V.J., Charman, W.N.A. and Naringrekar, V.H. (1985) Prodrugs, do they have advantages in clinical practice? Drugs 29, 455-473.
-
(1985)
Drugs
, vol.29
, pp. 455-473
-
-
Stella, V.J.1
Charman, W.N.A.2
Naringrekar, V.H.3
-
200
-
-
0000120844
-
Novel approaches to the design of safer drugs: Soft drugs and site-specific chemical delivery systems
-
Bodor, N. (1984) Novel approaches to the design of safer drugs: soft drugs and site-specific chemical delivery systems. Adv. Drug Res. 13, 225-331.
-
(1984)
Adv. Drug Res.
, vol.13
, pp. 225-331
-
-
Bodor, N.1
-
201
-
-
0342444609
-
In vivo elimination of dihydropyridine drug carriers from brain and blood of rats
-
Bodor, N., El-Kommos, M.E. and Nath, C. (1986) In vivo elimination of dihydropyridine drug carriers from brain and blood of rats. Bull. Pharm. Sci. Assiut Univ. 9, 14-29.
-
(1986)
Bull. Pharm. Sci. Assiut Univ.
, vol.9
, pp. 14-29
-
-
Bodor, N.1
El-Kommos, M.E.2
Nath, C.3
-
202
-
-
0019843193
-
Site-specific, sustained release of drugs to the brain
-
Bodor, N., Farag, H. and Brewster, M. (1981) Site-specific, sustained release of drugs to the brain. Science 214, 1370-1372.
-
(1981)
Science
, vol.214
, pp. 1370-1372
-
-
Bodor, N.1
Farag, H.2
Brewster, M.3
-
203
-
-
0024337493
-
Improved delivery through biological membranes. XL1. Brain-enhanced delivery of chlorambucil
-
Bodor, N., Vasudevan, V.D.W., Estes, K. and Brewster, M.E. (1989) Improved delivery through biological membranes. XL1. Brain-enhanced delivery of chlorambucil. Int. J. Pharmacol. 53, 195-208.
-
(1989)
Int. J. Pharmacol.
, vol.53
, pp. 195-208
-
-
Bodor, N.1
Vasudevan, V.D.W.2
Estes, K.3
Brewster, M.E.4
-
204
-
-
0027007974
-
Redox approaches to drug delivery to the central nervous system
-
Frankenheim, J. and Brown, R.M. (Eds), US Department of Health and Human Services, Rockville, MD
-
Brewster, M.E. and Bodor, N.(1992) Redox approaches to drug delivery to the central nervous system. In: Frankenheim, J. and Brown, R.M. (Eds), Bioavailability of Drugs to the Brain and the Blood-Brain Barrier, US Department of Health and Human Services, Rockville, MD, pp. 169-201.
-
(1992)
Bioavailability of Drugs to the Brain and the Blood-brain Barrier
, pp. 169-201
-
-
Brewster, M.E.1
Bodor, N.2
-
205
-
-
0026507070
-
Novel anticancer prodrugs of butyric acid
-
Nudelman, A., Ruse, M., Aviram, A., Rabizadeh, E., Shaklai, M., Zimrah, Y. and Rephaeli, A. (1992) Novel anticancer prodrugs of butyric acid. J. Med. Chem. 35, 687-694.
-
(1992)
J. Med. Chem.
, vol.35
, pp. 687-694
-
-
Nudelman, A.1
Ruse, M.2
Aviram, A.3
Rabizadeh, E.4
Shaklai, M.5
Zimrah, Y.6
Rephaeli, A.7
-
206
-
-
0028339741
-
Tributyrin: A prodrug of butyric acid for potential clinical application in differentiation therapy
-
Chen, Z.-X. and Breitman, T.R. (1994) Tributyrin: a prodrug of butyric acid for potential clinical application in differentiation therapy. Cancer Res. 54, 3494-3499.
-
(1994)
Cancer Res.
, vol.54
, pp. 3494-3499
-
-
Chen, Z.-X.1
Breitman, T.R.2
-
207
-
-
0027316830
-
Rapid alteration of c-myc and c-jun expression in leukemic cells induced to differentiate by a butyric acid prodrug
-
Rabizadeh, E., Shaklai, M., Nudelman, A., Eisenbach, L. and Rephaeli, A. (1993) Rapid alteration of c-myc and c-jun expression in leukemic cells induced to differentiate by a butyric acid prodrug. FEBS Lett. 328, 225-229.
-
(1993)
FEBS Lett.
, vol.328
, pp. 225-229
-
-
Rabizadeh, E.1
Shaklai, M.2
Nudelman, A.3
Eisenbach, L.4
Rephaeli, A.5
-
208
-
-
0028219470
-
Comparison between the effect of butyric acid and its prodrug pivaloyloxymethylbutyrate on histones hyperacetylation in an hl-60 leukemic cell line
-
Aviram, A., Zimrah, Y., Shaklai, M., Nudelman, A. and Rephaeli, A. (1994) Comparison between the effect of butyric acid and its prodrug pivaloyloxymethylbutyrate on histones hyperacetylation in an hl-60 leukemic cell line. Int. J. Cancer 56, 906-909.
-
(1994)
Int. J. Cancer
, vol.56
, pp. 906-909
-
-
Aviram, A.1
Zimrah, Y.2
Shaklai, M.3
Nudelman, A.4
Rephaeli, A.5
-
209
-
-
0342444597
-
Triazenylimidazoles, other triazenes, and imidazolo[5,1-d]-1,2,3,5-tetrazine-4(3H)-ones
-
Foye, W.O. (Ed.), American Chemical Society, Washington, DC
-
Shealy, Y.F. (1995) Triazenylimidazoles, other triazenes, and imidazolo[5,1-d]-1,2,3,5-tetrazine-4(3H)-ones. In: Foye, W.O. (Ed.), Cancer Chemotherapeutic Agents, American Chemical Society, Washington, DC, pp. 159-186.
-
(1995)
Cancer Chemotherapeutic Agents
, pp. 159-186
-
-
Shealy, Y.F.1
-
210
-
-
0002658038
-
Nitrogen mustard and related structures
-
Foye, W.O. (Ed.), American Chemical Society, Washington, DC
-
Struck, R.F., (1995) Nitrogen mustard and related structures. In: Foye, W.O. (Ed.), Cancer Chemotherapeutic Agents, American Chemical Society, Washington, DC, pp. 112-121.
-
(1995)
Cancer Chemotherapeutic Agents
, pp. 112-121
-
-
Struck, R.F.1
-
211
-
-
0028177704
-
Chemoprotection against cyclophosphamide-induced urotoxicity: Comparison of nine thiol protective agents
-
and references cited therein
-
Roberts, J.C., Franatio, D.J. and Zera, R.T. (1994) Chemoprotection against cyclophosphamide-induced urotoxicity: comparison of nine thiol protective agents. Anticancer Res. 14, 389-396, and references cited therein.
-
(1994)
Anticancer Res.
, vol.14
, pp. 389-396
-
-
Roberts, J.C.1
Franatio, D.J.2
Zera, R.T.3
-
212
-
-
0002042408
-
Mafosfamide - A derivative of 4-hydroxycyclophosphamide
-
Niemeyer, U., Engel, J., Hilgard, P., Peukert, M., Pohl, J. and Sindermann, H. (1989) Mafosfamide - a derivative of 4-hydroxycyclophosphamide. Prog. Clin. Biochem. Med. 9, 35-60.
-
(1989)
Prog. Clin. Biochem. Med.
, vol.9
, pp. 35-60
-
-
Niemeyer, U.1
Engel, J.2
Hilgard, P.3
Peukert, M.4
Pohl, J.5
Sindermann, H.6
-
213
-
-
0024334082
-
Proton-mediated liberation of aldophosphamide from a nontoxic prodrug: A strategy for tumor-selective activation of cytocidal drugs
-
Tietze, L.F., Neumann, M., Mollers, T., Fischer, R., Glusenkamp, K.-H., Rajewsky, M.F. and Jahde, E. (1989) Proton-mediated liberation of aldophosphamide from a nontoxic prodrug: a strategy for tumor-selective activation of cytocidal drugs. Cancer Res. 49, 4179-4184.
-
(1989)
Cancer Res.
, vol.49
, pp. 4179-4184
-
-
Tietze, L.F.1
Neumann, M.2
Mollers, T.3
Fischer, R.4
Glusenkamp, K.-H.5
Rajewsky, M.F.6
Jahde, E.7
-
214
-
-
0342444586
-
Novel stable bioactivated cyclophosphamide derivatives for selective cancer chemotherapy, synthesis of aldophosphamide acetal-glycosides and their glycoconjugates
-
Tietze, L.F., Fischer, R., Beller, M. and Seele, R. (1990) Novel stable bioactivated cyclophosphamide derivatives for selective cancer chemotherapy, synthesis of aldophosphamide acetal-glycosides and their glycoconjugates. Liebigs Ann. Chem. 151-157.
-
(1990)
Liebigs Ann. Chem.
, pp. 151-157
-
-
Tietze, L.F.1
Fischer, R.2
Beller, M.3
Seele, R.4
-
215
-
-
0021646134
-
The pharmacology of prodrugs of 5-fluorouracil and 1-β-D-arabinofuranosylcytosine
-
Hadfield, A.F. and Sartorelli, A.C. (1984) The pharmacology of prodrugs of 5-fluorouracil and 1-β-D-arabinofuranosylcytosine. Adv. Pharmacol. Chemother. 20, 21-67.
-
(1984)
Adv. Pharmacol. Chemother.
, vol.20
, pp. 21-67
-
-
Hadfield, A.F.1
Sartorelli, A.C.2
-
216
-
-
0000663450
-
Decreased toxicity and adverse reactions via prodrugs
-
Bundgaard, H. (Ed.), Elsevier, Amsterdam
-
Jones, G. (1985) Decreased toxicity and adverse reactions via prodrugs. In: Bundgaard, H. (Ed.), Design of Prodrugs, Elsevier, Amsterdam, pp. 199-241.
-
(1985)
Design of Prodrugs
, pp. 199-241
-
-
Jones, G.1
-
217
-
-
0028347566
-
Prodrugs of Ara-C
-
Wipf, P. and Li, W. (1994) Prodrugs of Ara-C. Drugs Future 19, 49-54.
-
(1994)
Drugs Future
, vol.19
, pp. 49-54
-
-
Wipf, P.1
Li, W.2
-
218
-
-
0342444587
-
Fluoropyrimidines
-
Foye, W.O. (Ed.), American Chemical Society, Washington, DC
-
Anantham, S. (1995) Fluoropyrimidines. In: Foye, W.O. (Ed.), Cancer Chemotherapeutic Agents, American Chemical Society, Washington, DC, pp. 49-58.
-
(1995)
Cancer Chemotherapeutic Agents
, pp. 49-58
-
-
Anantham, S.1
-
219
-
-
0342444585
-
Overview of new anticancer drugs developed in Japan
-
Kimura, K., Ota, K., Carter, S.K. and Friedmann T. (Eds), Excerpta Medica, Amsterdam
-
Ariyoshi, Y. (1994) Overview of new anticancer drugs developed in Japan. In: Kimura, K., Ota, K., Carter, S.K. and Friedmann T. (Eds), Cancer Chemotherapy: Challenges for the Future, Excerpta Medica, Amsterdam, pp. 157-217.
-
(1994)
Cancer Chemotherapy: Challenges for the Future
, pp. 157-217
-
-
Ariyoshi, Y.1
-
220
-
-
0018869414
-
Activation of Ftorafur [R,5-1-(tetrahydro-2-furanyl)-5-fluorouracil] to 5-fluorouracil and γ-butyrolactone
-
and references cited therein
-
Au, J.L-S. and Sadee, W. (1980) Activation of Ftorafur [R,5-1-(tetrahydro-2-furanyl)-5-fluorouracil] to 5-fluorouracil and γ-butyrolactone. Cancer Res. 40, 2814-2819, and references cited therein.
-
(1980)
Cancer Res.
, vol.40
, pp. 2814-2819
-
-
Au, J.L.-S.1
Sadee, W.2
-
221
-
-
0019287522
-
Amino acid and dipeptide derivatives of daunorubicin. 1. Synthesis, physicochemical properties, and lysosomal digestion
-
Masquelier, M., Baurain, R. and Trouet, A. (1980) Amino acid and dipeptide derivatives of daunorubicin. 1. Synthesis, physicochemical properties, and lysosomal digestion. J. Med. Chem. 23, 1166-1170.
-
(1980)
J. Med. Chem.
, vol.23
, pp. 1166-1170
-
-
Masquelier, M.1
Baurain, R.2
Trouet, A.3
-
222
-
-
0019301927
-
Amino acid and dipeptide derivatives of daunorubicin. 2. Cellular pharmacology and antitumor activity on L1210 leukemic cells in vitro and in vivo
-
Baurain, R., Masquelier, M., Deprez-de Campeneere, D. and Trouet, A. (1980) Amino acid and dipeptide derivatives of daunorubicin. 2. Cellular pharmacology and antitumor activity on L1210 leukemic cells in vitro and in vivo. J. Med. Chem. 23, 1171-1174.
-
(1980)
J. Med. Chem.
, vol.23
, pp. 1171-1174
-
-
Baurain, R.1
Masquelier, M.2
Deprez-De Campeneere, D.3
Trouet, A.4
-
223
-
-
0027050399
-
The anti-tumour effects of the prodrugs n-l-leucyl-doxorubicin and vinblastine-isoleucinate in human ovarian cancer xenografts
-
Boven, E., Hendriks, H.R., Erkelens, C.A.M. and Pinedo, H.M. (1992) The anti-tumour effects of the prodrugs n-l-leucyl-doxorubicin and vinblastine-isoleucinate in human ovarian cancer xenografts. Br. J. Cancer 66, 1044-1047.
-
(1992)
Br. J. Cancer
, vol.66
, pp. 1044-1047
-
-
Boven, E.1
Hendriks, H.R.2
Erkelens, C.A.M.3
Pinedo, H.M.4
-
224
-
-
0027318628
-
Aspects of the cellular pharmacology of N-l-leucyldoxorubicin in human tumor cell lines
-
Bennis, S., Garcia, C. and Robert, J. (1993) Aspects of the cellular pharmacology of N-l-leucyldoxorubicin in human tumor cell lines. Biochem. Pharmacol. 45, 1929-1931.
-
(1993)
Biochem. Pharmacol.
, vol.45
, pp. 1929-1931
-
-
Bennis, S.1
Garcia, C.2
Robert, J.3
-
225
-
-
0026755410
-
Analysis and pharmacokinetics of a new prodrug N-l-leucyldoxorubicin and its metabolites inplasma using HPLC with fluorescence detection
-
Jong, J.D., Vermerken, J.B. and Van Der Vijgh, W.J.F. (1992) Analysis and pharmacokinetics of a new prodrug N-l-leucyldoxorubicin and its metabolites inplasma using HPLC with fluorescence detection. J. Pharm. Biomed. Anal. 10, 309-314.
-
(1992)
J. Pharm. Biomed. Anal.
, vol.10
, pp. 309-314
-
-
Jong, J.D.1
Vermerken, J.B.2
Van Der Vijgh, W.J.F.3
-
226
-
-
0026589540
-
Human pharmacokinetics of N-l-leucyl-doxorubicin, a new anthracycline derivative, and its correlation with clinical toxicities
-
Canal, P., Roberts, J., Ramon, M., Baurain, R., Tresca, P., de Forni, M., Marty, M., Pujade-Lauraine, E., Bugat, R., Magis, A. and Belopmme, D. (1992) Human pharmacokinetics of N-l-leucyl-doxorubicin, a new anthracycline derivative, and its correlation with clinical toxicities. Clin. Pharmacol. Ther. 51, 249-259.
-
(1992)
Clin. Pharmacol. Ther.
, vol.51
, pp. 249-259
-
-
Canal, P.1
Roberts, J.2
Ramon, M.3
Baurain, R.4
Tresca, P.5
De Forni, M.6
Marty, M.7
Pujade-Lauraine, E.8
Bugat, R.9
Magis, A.10
Belopmme, D.11
-
227
-
-
0027052703
-
Plasma pharmacokinetics and pharmacodynamics of a new prodrug N-l-leucyldoxorubicin and its metabolites in a phase I clinical trial
-
de Jong, J., Geijssen, G.J., Munniksma, C.N., Vermorken, J.B. and Van der Vijgh, W.J.F. (1992) Plasma pharmacokinetics and pharmacodynamics of a new prodrug N-l-leucyldoxorubicin and its metabolites in a phase I clinical trial. J. Clin. Oncol. 10, 1897-1906.
-
(1992)
J. Clin. Oncol.
, vol.10
, pp. 1897-1906
-
-
De Jong, J.1
Geijssen, G.J.2
Munniksma, C.N.3
Vermorken, J.B.4
Van Der Vijgh, W.J.F.5
-
228
-
-
85030200187
-
Synthesis and proteolytic cleavage of 3′-N-peptidyl-adriamycin prodrugs
-
Rivier, J.E. and Marshall, G.R. (Eds), ESCOM, Leiden
-
King, H.D., DeVirgilio, M.K., Martin, J.D., Radcliffe, R.D. and Coughlin, D.J. (1990) Synthesis and proteolytic cleavage of 3′-N-peptidyl-adriamycin prodrugs. In: Rivier, J.E. and Marshall, G.R. (Eds), Peptides - Chemistry, Structure and Biology, ESCOM, Leiden, pp. 137-139.
-
(1990)
Peptides - Chemistry, Structure and Biology
, pp. 137-139
-
-
King, H.D.1
DeVirgilio, M.K.2
Martin, J.D.3
Radcliffe, R.D.4
Coughlin, D.J.5
-
229
-
-
0027933231
-
Pharmacokinetics, tissue distribution, and biliary excretion of FT-ADM after intravenous administration of DA-125, a prodrug of FT-ADM to dogs. A new adriamycin analog containing fluorine
-
Yoon, E.J., Lee, E.D., Yoon, W.H., Shim, H.J., Lee, S.D., Kim, W.B., Yang, J. and Lee, M.G. (1994) Pharmacokinetics, tissue distribution, and biliary excretion of FT-ADM after intravenous administration of DA-125, a prodrug of FT-ADM to dogs. A new adriamycin analog containing fluorine. Int. J. Pharm. 109, 181-187.
-
(1994)
Int. J. Pharm.
, vol.109
, pp. 181-187
-
-
Yoon, E.J.1
Lee, E.D.2
Yoon, W.H.3
Shim, H.J.4
Lee, S.D.5
Kim, W.B.6
Yang, J.7
Lee, M.G.8
-
230
-
-
0028082358
-
Pharmacokinetics of FT-ADM after intravenous administration of DA-125, a prodrug of FT-ADM to rats. A new adriamycin analog containing fluorine
-
Shim, H.J., Lee, E.D., Yoon, E.J., Lee, S.D., Kim, W.B., Yang, J. and Lee, M.G. (1994) Pharmacokinetics of FT-ADM after intravenous administration of DA-125, a prodrug of FT-ADM to rats. A new adriamycin analog containing fluorine. Int. J. Pharm. 103, 147-154.
-
(1994)
Int. J. Pharm.
, vol.103
, pp. 147-154
-
-
Shim, H.J.1
Lee, E.D.2
Yoon, E.J.3
Lee, S.D.4
Kim, W.B.5
Yang, J.6
Lee, M.G.7
-
232
-
-
0003041822
-
Lipophilic prodrugs and the promotion of intestinal lymphatic drug transport
-
Charman, W.N. and Stella, V.J. (Eds), CRC Press, Boca Raton, FL
-
Stella, V.J. and Pochopin, N.L. (1992) Lipophilic prodrugs and the promotion of intestinal lymphatic drug transport. In: Charman, W.N. and Stella, V.J. (Eds), Lymphatic Transport of Drugs, CRC Press, Boca Raton, FL, pp. 181-210.
-
(1992)
Lymphatic Transport of Drugs
, pp. 181-210
-
-
Stella, V.J.1
Pochopin, N.L.2
-
233
-
-
0014575950
-
The effects of some steroidal alkylating agents on experimental animal mammary tumor and leukemia systems
-
Wall, M.F., Abernathy, G.S., Carroll, F.L. and Taylor, D.J. (1969) The effects of some steroidal alkylating agents on experimental animal mammary tumor and leukemia systems. J. Med. Chem. 12, 810-818.
-
(1969)
J. Med. Chem.
, vol.12
, pp. 810-818
-
-
Wall, M.F.1
Abernathy, G.S.2
Carroll, F.L.3
Taylor, D.J.4
-
234
-
-
0020556575
-
1,3-Dipalmitoylglycerol ester of chlorambucil as a lymphotropic, orally administrable antineoplastic agent
-
Garzon-Aburbeh, A., Pouapaert, J.H., Claesen, M., Dumont, P. and Atassi, G. (1983) 1,3-Dipalmitoylglycerol ester of chlorambucil as a lymphotropic, orally administrable antineoplastic agent. J. Med. Chem. 26, 1200-1203.
-
(1983)
J. Med. Chem.
, vol.26
, pp. 1200-1203
-
-
Garzon-Aburbeh, A.1
Pouapaert, J.H.2
Claesen, M.3
Dumont, P.4
Atassi, G.5
-
235
-
-
0342879115
-
1,3-Dipalmitoyl-(4-bis(2-chloroethyl)amino)-phenylalaninoyl a stable and lymphotropic prodrug of melphalan
-
Deverre, J.R., Letourneux, Y, Couvreur, P. and Benoit, J.P. (1991) 1,3-Dipalmitoyl-(4-bis(2-chloroethyl)amino)-phenylalaninoyl) a stable and lymphotropic prodrug of melphalan. Proc. Int. Symp. Control. Release Bioact. Mater. 18, 215-216.
-
(1991)
Proc. Int. Symp. Control. Release Bioact. Mater.
, vol.18
, pp. 215-216
-
-
Deverre, J.R.1
Letourneux, Y.2
Couvreur, P.3
Benoit, J.P.4
|